<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html id="nojs" xmlns="http://www.w3.org/1999/xhtml" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:og="http://ogp.me/ns#" xml:lang="en-GB" lang="en-GB" xmlns:wb=“http://open.weibo.com/wb”>

<head>

   
  
      
  
                  
  
                  
  
            
  
            
            
    <title>Trials | Full text | The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial</title>
<link rel="shortcut icon" type="image/x-icon" href="/images/icon/10096/favicon.ico" />
<link rel="apple-touch-icon" sizes="72x72" href="/sites/10096/images/70.gif" />
<meta http-equiv="X-UA-Compatible" content="IE=7" />


                
    
		
		
		
		
<!-- <?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:cc="http://web.resource.org/cc/" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
<cc:Work rdf:about="http://www.trialsjournal.com/content/16/1/25">
<cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
</cc:Work>
<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
<cc:permits rdf:resource="http://web.resource.org/cc/Reproduction"/>
<cc:permits rdf:resource="http://web.resource.org/cc/Distribution"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Notice"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Attribution"/>
<cc:permits rdf:resource="http://web.resource.org/cc/DerivativeWorks"/>
</cc:License>
<item rdf:about="http://www.trialsjournal.com/content/16/1/25">
<title>The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial</title>
<dc:title>The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial</dc:title>
<dc:creator>Glenthøj, Louise B</dc:creator>
<dc:creator>Fagerlund, Birgitte</dc:creator>
<dc:creator>Randers, Lasse</dc:creator>
<dc:creator>Hjorthøj, Carsten R</dc:creator>
<dc:creator>Wenneberg, Christina</dc:creator>
<dc:creator>Krakauer, Kristine</dc:creator>
<dc:creator>Vosgerau, Astrid</dc:creator>
<dc:creator>Gluud, Christian</dc:creator>
<dc:creator>Medalia, Alice</dc:creator>
<dc:creator>Roberts, David L</dc:creator>
<dc:creator>Nordentoft, Merete</dc:creator>
<dc:identifier>info:doi/10.1186/s13063-014-0542-8</dc:identifier>
<dc:identifier>info:pmid/25623736</dc:identifier>
<dc:source>Trials 2015, 16:25</dc:source>
<dc:date>2015-01-27</dc:date>

<prism:publicationName>Trials</prism:publicationName>
<prism:publicationDate>2015-01-27</prism:publicationDate>
<prism:volume>16</prism:volume>
<prism:number>1</prism:number>
<prism:section>Study protocol</prism:section>
<prism:startingPage>25</prism:startingPage>
<prism:copyright>2015 Glenthøj et al.; licensee BioMed Central.</prism:copyright>
</item>
</rdf:RDF>
 -->
 
 
<meta name="citation_journal_title" content="Trials" />
<meta name="citation_publisher" content="BioMed Central Ltd" />


<meta name="citation_author" content="Louise B Glenthøj" />
<meta name="citation_author_institution" content="Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, DK-2400, Denmark" />
<meta name="citation_author_institution" content="Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Glostrup, DK-2600, Denmark" />
<meta name="citation_author" content="Birgitte Fagerlund" />
<meta name="citation_author_institution" content="Centre for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Centre Glostrup, Copenhagen University Hospital, Glostrup, DK-2600, Denmark" />
<meta name="citation_author_institution" content="Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Glostrup, DK-2600, Denmark" />
<meta name="citation_author" content="Lasse Randers" />
<meta name="citation_author_institution" content="Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, DK-2400, Denmark" />
<meta name="citation_author_institution" content="Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Glostrup, DK-2600, Denmark" />
<meta name="citation_author" content="Carsten R Hjorthøj" />
<meta name="citation_author_institution" content="Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, DK-2400, Denmark" />
<meta name="citation_author" content="Christina Wenneberg" />
<meta name="citation_author_institution" content="Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, DK-2400, Denmark" />
<meta name="citation_author_institution" content="Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Glostrup, DK-2600, Denmark" />
<meta name="citation_author" content="Kristine Krakauer" />
<meta name="citation_author_institution" content="Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, DK-2400, Denmark" />
<meta name="citation_author_institution" content="Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Glostrup, DK-2600, Denmark" />
<meta name="citation_author" content="Astrid Vosgerau" />
<meta name="citation_author_institution" content="Centre for Rehabilitation for Brain Injury, Copenhagen, DK-2300, Denmark" />
<meta name="citation_author_institution" content="Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, DK-2400, Denmark" />
<meta name="citation_author" content="Christian Gluud" />
<meta name="citation_author_institution" content="Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DK-2100, Denmark" />
<meta name="citation_author" content="Alice Medalia" />
<meta name="citation_author_institution" content="Columbia University Medical Center, New York 10032, NY, USA" />
<meta name="citation_author" content="David L Roberts" />
<meta name="citation_author_institution" content="Department of Psychiatry, Division of Schizophrenia and Related Disorders, University of Texas Health Science Center, San Antonio 78229, TX, USA" />
<meta name="citation_author" content="Merete Nordentoft" />
<meta name="citation_author_institution" content="Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, DK-2400, Denmark" />
<meta name="citation_author_institution" content="Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Glostrup, DK-2600, Denmark" />


<meta name="citation_issn" content="1745-6215" />
<meta name="citation_title" content="The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial" />
<meta name="citation_volume" content="16" />
<meta name="citation_issue" content="1" />
<meta name="citation_date" content="2015-01-27" />
<meta name="citation_firstpage" content="25" />
<meta name="citation_doi" content="10.1186/s13063-014-0542-8" />
<meta name="citation_pdf_url" content="http://www.trialsjournal.com/content/pdf/s13063-014-0542-8.pdf" />
<meta name="citation_pmid" content="25623736" />
<link rel="alternate" type="application/pdf" title="PDF" href="http://www.trialsjournal.com/content/pdf/s13063-014-0542-8.pdf" />
<meta name="title" content="The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial" />
<meta name="description" content="Cognitive deficits are a distinct feature among people at ultra-high risk (UHR) for psychosis and pose a barrier to functional recovery. Insufficient evidence exists on how to ameliorate these cognitive deficits in patients at UHR for psychosis and hence improve daily living and quality of life. The aim of the trial is to investigate whether cognitive remediation can improve cognitive and psychosocial function in patients at UHR for psychosis." />

<meta name="dc.title" content="The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial" />
<meta name="dc.creator" content="Glenthøj, Louise B" />
<meta name="dc.creator" content="Fagerlund, Birgitte" />
<meta name="dc.creator" content="Randers, Lasse" />
<meta name="dc.creator" content="Hjorthøj, Carsten R" />
<meta name="dc.creator" content="Wenneberg, Christina" />
<meta name="dc.creator" content="Krakauer, Kristine" />
<meta name="dc.creator" content="Vosgerau, Astrid" />
<meta name="dc.creator" content="Gluud, Christian" />
<meta name="dc.creator" content="Medalia, Alice" />
<meta name="dc.creator" content="Roberts, David L" />
<meta name="dc.creator" content="Nordentoft, Merete" />
<meta name="dc.description" content="Cognitive deficits are a distinct feature among people at ultra-high risk (UHR) for psychosis and pose a barrier to functional recovery. Insufficient evidence exists on how to ameliorate these cognitive deficits in patients at UHR for psychosis and hence improve daily living and quality of life. The aim of the trial is to investigate whether cognitive remediation can improve cognitive and psychosocial function in patients at UHR for psychosis." />
<meta name="dc.source" content="Trials 2015 16:25" />
<meta name="dc.format" content="text/html" />
<meta name="dc.publisher" content="BioMed Central Ltd" />
<meta name="dc.date" content="2015-01-27" />
<meta name="dc.type" content="Study protocol" />
<meta name="dc.identifier" content="10.1186/s13063-014-0542-8" />
<meta name="dc.identifier" content="info:pmid/25623736" />
<meta name="dc.language" content="en" />
<meta name="dc.copyright" content="2015 Glenthøj et al.; licensee BioMed Central." />
<meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0/" />
<meta name="dc.rightsAgent" content="reprints@biomedcentral.com" />

<meta name="prism.issn" content="1745-6215" />
<meta name="prism.publicationName" content="Trials" />
<meta name="prism.publicationDate" content="2015-01-27" />
<meta name="prism.volume" content="16" />
<meta name="prism.number" content="1" />
<meta name="prism.section" content="Study protocol" />
<meta name="prism.startingPage" content="25" />
<meta name="prism.copyright" content="2015 Glenthøj et al.; licensee BioMed Central." />
<meta name="prism.rightsAgent" content="reprints@biomedcentral.com" />


        <meta name="citation_abstract_html_url" content="http://www.trialsjournal.com/content/16/1/25/abstract" />
            <meta name="citation_fulltext_html_url" content="http://www.trialsjournal.com/content/16/1/25" />
            <link rel='alternate' type='text/xml' title='XML version' href='http://www.trialsjournal.com/content/download/xml/s13063-014-0542-8.xml' />
            <link rel="image_src" href="http://www.trialsjournal.com/content/figures/s13063-014-0542-8-toc.gif" />
    
    
    
    
                    
    

<script type="text/javascript">
// must run before css
document.documentElement.id = "js";
</script>



						
   
  
      
  
                  
  
                  
  
            
  
            
            



						
        <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery-1.8.2.min-0.js"></script>

	                <link rel="stylesheet" type="text/css" href="/css/main-0.css" media="screen, print"/>
    
                <link rel="stylesheet" type="text/css" href="/css/plugins-0.css" media="screen, print"/>
    



    

			                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/articles-0.css" media="screen, print"/>
    	

    

    <link rel="stylesheet" type="text/css" href="/css/themes/10096.css" media="screen, print"/>


                <link rel="stylesheet" type="text/css" href="/css/media/print-0.css" media="print"/>
    



<!--[if IE]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie-0.css"/>
    <![endif]-->

<!--[if IE 7]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie7-0.css"/>
    <![endif]-->
			
<script type="text/javascript">
    //configuration
    OAS_url = '//oas.biomedcentral.com/RealMedia/ads/';

	// control of advert's position on page [AMC]
    
    	
	
    OAS_sitepage = "trialsjournal.com/article/10.1186/s13063/014/0542/8";
    	
		OAS_listpos = 'Top,x96,Right3';
	
	
			
		OAS_query = '';
		
	

    OAS_target = '_top';
    //end of configuration
    OAS_version = 10;
    OAS_rn = '001234567890'; OAS_rns = '1234567890';
    OAS_rn = new String (Math.random()); OAS_rns = OAS_rn.substring (2, 11);
    function OAS_NORMAL(pos) {
		document.write('<a href="' + OAS_url + 'click_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" target="' + OAS_target + '">');
		document.write('<img src="' + OAS_url + 'adstream_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" border="0"/></a>');
    }
    
	function refererTerms(referer) {

	if(referer.match("q=") != null) {
		referer = referer.split("q=");
		referer = referer[1].split("&");
		referer = referer[0];
	} else {
		referer = referer;
	}

		if(referer.match("%20") != null && referer.match("%20").length >= 1) {
			referer =  referer.replace(/%20/gi,"+");
			return referer;
		} else { 
			return referer; 
		}
	}
 </script>


 <script type="text/javascript">
	// Set the version of JavaScript to 10 for a Browser 'Mozilla/3' on webTV 
    OAS_version = 11;
    if ((navigator.userAgent.indexOf('Mozilla/3') != -1) || (navigator.userAgent.indexOf('Mozilla/4.0 WebTV') != -1)) {
     OAS_version = 10; }
    if (OAS_version >= 11) {
    document.write('<scr' + 'ipt type="text/javascript" src="' + OAS_url + 'adstream_mjx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '?' + OAS_query + '"><\/script>'); }
</script>
	
<script type="text/javascript">
    document.write('');
	
    function OAS_AD(pos) {
        if (OAS_version >= 11)
         OAS_RICH(pos);
        else
         OAS_NORMAL(pos);
    }
 </script>
	





<script type="text/javascript">
    jsonLoaders = function(){
        var _loaders = [];
        return {
            register: function(config){
                config.prefix = config.prefix || '/webapi/1.0/blogs/';
                config.feedLength = config.feedLength || 3;

                _loaders.push(config);
            },
            list: function(){return _loaders}
        };
    }();

    function totext() {
	    document.write('<a href="javascript:returnToText();">Return to text</a>');
    }

    function retrieve_doi(){
        var metas = document.getElementsByTagName('meta');
        var i;
        for (i = 0; i < metas.length; i++)
            if (metas[i].getAttribute('name') == "citation_doi")
                break;
        var citation_doi = metas[i].getAttribute('content');
        return citation_doi;
    }

</script>





    <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script>
        <link title="Latest articles" rel="alternate" href="http://www.trialsjournal.com/latest/rss" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Most viewed" rel="alternate" href="http://www.trialsjournal.com/mostviewed/rss/" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Latest comments" rel="alternate" href="http://www.trialsjournal.com/latestcomments/rss" type="application/rss+xml" exposeToHeader="true"/>
    


	<script type="text/javascript">
	var _gaq = _gaq || [];
	_gaq.push(['_setAccount', 'UA-9663741-5']);
	_gaq.push(['_gat._anonymizeIp']);
	_gaq.push(['_setLocalRemoteServerMode']);
	
	/*for cross domain tracking*/
	//_gaq.push(['_setAllowLinker', true]);
    //_gaq.push(['_setDomainName', 'trialsjournal.com']); //this journal's domain
	/**/
	
		_gaq.push(['_trackPageview']); 

	(function() {
		var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
		ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
		var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);

		//var iframe = document.getElementById('casesdb-search-widget');
		//if(iframe !== null) {
		//	var pageTracker = _gat._getTrackerByName();
		//	iframe.src = pageTracker._getLinkerUrl('http://www.casesdatabase.com/');
		//}
	})();
	</script>

	
        </head>


<body class=" theme    ">


        



   
  
      
  
                  
  
                  
  
            
  
            
            

    

<div id="oas-campaign" style="display:none">trialsjournal.com/article/10.1186/s13063/014/0542/8</div>
<div id="oas-positions" style="display:none">Bottom,Top</div>

<div id="branding" role="banner">
                			
		<dl class="google-ad wide ">
	<dt class="hide">
					<a class="banner-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising"></a>
				
			</dt>
		<dd>

		<!-- OAS AD 'Top' begin -->
		<script type="text/javascript">
		OAS_AD('Top');

		</script>
		<!-- OAS AD 'Top' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad wide noscript">  
    <dt class="hide"></dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/014/0542/8/19031191480@Top?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/014/0542/8/19936392510@Top?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
			            <div class="sup-panel-outer">
        <div class="sup-panel-inner">

            <style>
  #nojs li.greeting, #nojs li#loginLink {display:none;}
</style>


<ul id="login" class="login">

    <noscript><li><a href="/log"><img class="greeting" src="/images/log.gif"/></a></li></noscript>
    
    <li id="welcome"><span id="username"></span></li>

    <li id="loginLink"><a href=""></a></li>
    
    
</ul>

<script>

function login() {

/* cookie getter/setter */
var allCookies = {
  getItem: function (sKey) {
    if (!sKey || !this.hasItem(sKey)) { return null; }
    return unescape(document.cookie.replace(new RegExp("(?:^|.*;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=\\s*((?:[^;](?!;))*[^;]?).*"), "$1"));
  },
  setItem: function (sKey, sValue, vEnd, sPath, sDomain, bSecure) {
    if (!sKey || /^(?:expires|max\-age|path|domain|secure)$/i.test(sKey)) { return; }
    var sExpires = "";
    if (vEnd) {
      switch (vEnd.constructor) {
        case Number:
          sExpires = vEnd === Infinity ? "; expires=Tue, 19 Jan 2038 03:14:07 GMT" : "; max-age=" + vEnd;
          break;
        case String:
          sExpires = "; expires=" + vEnd;
          break;
        case Date:
          sExpires = "; expires=" + vEnd.toGMTString();
          break;
      }
    }
    document.cookie = escape(sKey) + "=" + escape(sValue) + sExpires + (sDomain ? "; domain=" + sDomain : "") + (sPath ? "; path=" + sPath : "") + (bSecure ? "; secure" : "");
  },
  removeItem: function (sKey, sPath) {
    if (!sKey || !this.hasItem(sKey)) { return; }
    document.cookie = escape(sKey) + "=; expires=Thu, 01 Jan 1970 00:00:00 GMT" + (sPath ? "; path=" + sPath : "");
  },
  hasItem: function (sKey) {
    return (new RegExp("(?:^|;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=")).test(document.cookie);
  },
  keys: /* optional method: you can safely remove it! */ function () {
    var aKeys = document.cookie.replace(/((?:^|\s*;)[^\=]+)(?=;|$)|^\s*|\s*(?:\=[^;]*)?(?:\1|$)/g, "").split(/\s*(?:\=[^;]*)?;\s*/);
    for (var nIdx = 0; nIdx < aKeys.length; nIdx++) { aKeys[nIdx] = unescape(aKeys[nIdx]); }
    return aKeys;
  }
};

// converts cookie into js object
function parseCookie(cookie) {

    cookie = cookie.split("&");
    var obj = {};

    for(var i = 0; i < cookie.length; i++) {

        var c = cookie[i].split("=");

        c[0] = c[0].replace('"','');
        
        obj[c[0]] = c[1];

    }
    return obj;
}

    var cookie = allCookies.getItem("bmccookie");

    var obj = (cookie != null) ? parseCookie(cookie) : {};
    

        var welcome = "";

        if(obj.hasOwnProperty("fname")) {

            // insert user welcome
            welcome = obj.fname.replace(/\+/g, " ") + " " + obj['lname'].replace(/\+/g," ");

            if(jQuery("#welcome").length > 0) {
              jQuery("#welcome").prepend("<strong>Welcome</strong> ");
              jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log off");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logoff");

            window.bmcloggedon = true;


        } else if(obj.hasOwnProperty("institution_name")) {

            // insert institution name
            welcome = obj["institution_name"].replace(/\+/g," ");
            
            if(jQuery("#welcome").length > 0) { 
                jQuery("#welcome").prepend("<strong>Welcome</strong> ");
                jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;


        } else {
            jQuery("#welcome").innerHTML = "";
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;

        }


        // if athens login cookie doesn't exist and the athens login link is visible then remove it.
        if(allCookies.hasItem("athens") != true && document.getElementById("loginAthensLink") != null) {
          jQuery("#loginAthensLink").hide();
        }

}

login();


</script>

            <ul class="nav-sup">

    
        <li id="BMC" class="current">
            <a href="http://www.biomedcentral.com/"><span class="img-title">&nbsp;</span>
            <span class="text-title">BioMed Central</span></a>
        </li>
		
        		<li><a href="http://www.biomedcentral.com/journals"><span>Journals</span></a></li>
		
								<li>
				<a href="http://www.biomedcentral.com/gateways"><span>Gateways</span></a>
			</li>
					    	
</ul>
        </div>
    </div>
    <div class="branding-inner">

        

    
<style>
.survey {
	margin: 10px 0;
}
.survey, .survey .survey-sentence {
	font-size: 13px;
}
.survey-button a, .survey-button a:active, .survey-button a:visited, .survey-button a:hover  {
    color: #FFFFFF;
    text-decoration: none;
}
.survey-button {
	background-color: #FFA500;
    border-radius: 5px;
    color: #FFFFFF;
    font-weight: bold;
    font-size: 13px;
    font-weight: bold;
    padding: 5px 13px;
    background: #ef8142; /* Old browsers */
	background: -moz-linear-gradient(top,  #ef8142 0%, #ef8142 50%, #a64510 100%, #a64510 100%); /* FF3.6+ */
	background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,#ef8142), color-stop(50%,#ef8142), color-stop(100%,#a64510), color-stop(100%,#a64510)); /* Chrome,Safari4+ */
	background: -webkit-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Chrome10+,Safari5.1+ */
	background: -o-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Opera 11.10+ */
	background: -ms-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* IE10+ */
	background: linear-gradient(to bottom,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* W3C */
	filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ef8142', endColorstr='#a64510',GradientType=0 ); /* IE6-9 */

}
</style>




          <div class="logo">
        <a href="/"><img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" /></a>     
      </div>    
        
                    



            <div id="impact-factor" class="official">
    <img src="/images/branding/official.gif" alt="official impact factor" title="2.12"/>
    <span id="impact-factor-value">2.12</span>
</div>
    
                            

<div class="module search gray small  " role="search">
    <div class="module-inner padded">
        <form method="get" class="searchForm"
              action=" /quickSearchRedirectURL "
              onsubmit="window.location.href=this['url'].value + '?terms=' + encodeURIComponent(this['terms'].value); return false;">
            <fieldset class="search">
			                <span>
                    Search <select name="url">
                                <option value="http://www.trialsjournal.com/search/results" selected>Trials</option>
                                <option value="http://www.biomedcentral.com/search/results">BioMed Central</option>
                           </select> for
                </span>
                            <input id="searchTerms" name="terms" type="text" alt="Search terms" class="text " />
                 <button class="w37" value="Go" type="submit">Go</button>
            </fieldset>
        </form>
    </div>
	<a class="advanced-search" href="/search">Advanced search</a>
</div> 

                        <div id="mobile-nav-list" >

	<ul class="primary-nav" role="navigation">
		<li     ><a href="/"><span id="home-tab">Home</span></a></li>
														<li             class="current"
    ><a href="/content"><span id="articles-tab">Articles</span></a></li>
										
	

	
            <li     ><a href="/authors/instructions"><span id="authors-tab">Authors</span></a></li>
        <li     ><a href="/about/reviewers"><span id="reviewers-tab">Reviewers</span></a></li>
    		<li     ><a href="/about"><span id='about-tab'>About this journal</span></a></li>
	<li     ><a href="/my"><span id="my-tab">My Trials</span></a></li>
		
    		</ul>
</div>
            </div>
</div>

<hr class="hide" />
<div class="container">
	<div id="content"  class="overflow-visible"  role="main">
			    
	

<!--div class="branding-mobile">
		<h1 class="logo">
	    <a href="/">
		    <img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" />
		</a>
		</h1>
	</div><br/-->



			
	



<div class="outline-wrapper block mobile-hidden" id="left-article-box">
<ul id="box-outline" class="box">
<ul id="outline" class="outline">
   <li>
      <a href="#">Top</a>
   </li>
   <li>
      <a href="#abs">Abstract</a>
   </li>
   <li>
      <a href="#sec1">Background</a>
   </li>
   <li>
      <a href="#sec2">Methods</a>
   </li>
   <li>
      <a href="#sec3">Discussion</a>
   </li>
   <li>
      <a href="#sec4">Trial status</a>
   </li>
   <li>
      <a href="#sec5">Abbreviations</a>
   </li>
   <li>
      <a href="#sec6">Competing interests</a>
   </li>
   <li>
      <a href="#sec7">Authors’ contributions</a>
   </li>
   <li>
      <a href="#ack">Acknowledgements</a>
   </li>
   <li class="lowest">
      <a href="#refs">References</a>
   </li>
</ul>
</ul>

<dl id="box-outline1">
</dl>

				



</div>



<div class="mobile-hidden" id="right-panel">
 	
<div id="mobile-sidebar">
	<div id="mobile-sidebar-tab">
		<span>
			<a href="#" id="mobile-sidebar-tab-link"><img src="/images/sidebar-hidden.png"><img style="display:none;" src="/images/sidebar-shown.png"></a>
		</span>
	</div>	<div id="mobile-sidebar-list">

<div id="article-navigation-bar">
    <div class="issue-information block">
        <h5><a href="http://www.trialsjournal.com"><strong>Trials</strong></a></h5>
 		        <ul class="square normal">
            <li><a href="http://www.trialsjournal.com/content/16">Volume 16</a></li>
				
                    </ul>
    </div>

    <div class="article-information block" id="article-info">
        


<div id="viewing-options-links">
	<h5>Viewing options</h5>
	<ul class="square normal">
        
            <li>
                             <a onclick="_gaq.push(['_trackEvent', 'Abstract', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/16/1/25/abstract">Abstract</a>
                        </li>
        				<li>
							<strong>Full text</strong>
					</li>
				
		<li class="pdfFileSize">
			<a onclick="_gaq.push(['_trackEvent', 'PDF download', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/pdf/s13063-014-0542-8.pdf">PDF</a>
			<span>(746KB)</span>
		</li>

        
			</ul>

        
</div>
		
<div id="associated-material-links">
    <h5>Associated material</h5>
    <ul class="square normal">
                        <li>
            <a onclick="_gaq.push(['_trackEvent', 'Pubmed record', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/pubmed/25623736">PubMed record</a>
        </li>
                            <li><a onclick="_gaq.push(['_trackEvent', 'Article metrics', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/16/1/25/about">Article metrics</a></li>
                <li>
                        <a onclick="_gaq.push(['_trackEvent', 'Readers comments', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/16/1/25/comments">Readers' comments </a>
                    </li>
        <li>
                            <a onclick="_gaq.push(['_trackEvent', 'Pre-publication history', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/16/1/25/prepub">Pre-publication history</a>                    </li>
    </ul>
</div>
		




<div id="related-literature-links">
    <h5>Related literature</h5>
    <ul class="normal">
                    <li><a onclick="_gaq.push(['_trackEvent', 'Citied by', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://www.trialsjournal.com/content/16/1/25/about#citations">Cited by</a></li>
                <li id="google-blog-search"><a onclick="_gaq.push(['_trackEvent', 'Google blog search', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://www.google.com/search?tbm=blg&hl=en&amp;source=hp&amp;biw=1280&amp;bih=899&amp;q=%22The+FOCUS+trial%3A+cognitive+remediation+plus+standard+treatment+versus+standard+treatment+for+patients+at+ultra-high+risk+for+psychosis%3A+study+protocol+for+a+randomised+controlled+trial%22&amp;btnG=Search">Google blog search</a></li>
        <h6>Other articles by authors</h6>
        <li>
            <a class="collapser"><i>&nbsp;</i>on Google Scholar</a>
<ul id="authg" class="hidebeforeload">                         <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22LB+Glenthøj%22">Glenthøj LB</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22B+Fagerlund%22">Fagerlund B</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22L+Randers%22">Randers L</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22CR+Hjorthøj%22">Hjorthøj CR</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22C+Wenneberg%22">Wenneberg C</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22K+Krakauer%22">Krakauer K</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22A+Vosgerau%22">Vosgerau A</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22C+Gluud%22">Gluud C</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22A+Medalia%22">Medalia A</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22DL+Roberts%22">Roberts DL</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22M+Nordentoft%22">Nordentoft M</a>
            </li>
            </ul>          </li>
                <li>
            		<a class="collapser"><i>&nbsp;</i>on PubMed</a>
	<ul id="authpm" class="hidebeforeload"> 									<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Glenthøj_LB%20[Author]">Glenthøj LB</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Fagerlund_B%20[Author]">Fagerlund B</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Randers_L%20[Author]">Randers L</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Hjorthøj_CR%20[Author]">Hjorthøj CR</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Wenneberg_C%20[Author]">Wenneberg C</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Krakauer_K%20[Author]">Krakauer K</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Vosgerau_A%20[Author]">Vosgerau A</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Gluud_C%20[Author]">Gluud C</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Medalia_A%20[Author]">Medalia A</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Roberts_DL%20[Author]">Roberts DL</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Nordentoft_M%20[Author]">Nordentoft M</a>
				</li>
						</ul > 	        </li>
    </ul>     <h6>Related articles/pages</h6>
    <ul class="square normal">
        <li><a onclick="_gaq.push(['_trackEvent', 'on google', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://www.google.co.uk/search?hl=en&amp;q=related:http://www.trialsjournal.com/content/16/1/25">on Google</a></li>
        <li><a onclick="_gaq.push(['_trackEvent', 'on google scholar', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://scholar.google.com/scholar?q=related:http://www.trialsjournal.com/content/16/1/25">on Google Scholar</a></li>
                    <li><a onclick="_gaq.push(['_trackEvent', 'on Pubmed', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/pubmed/related/25623736">on PubMed</a></li>
            </ul>

</div>		
        
    
    
        

    	






<h5>Tools</h5>
	<ul class="square normal">
									<li>
						<a onclick="_gaq.push(['_trackEvent', 'download references', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/16/1/25/citation">Download references</a>
					</li>
				<li><a onclick="_gaq.push(['_trackEvent', 'download xml', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/download/xml/s13063-014-0542-8.xml">Download XML</a></li>
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'email2friend', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/16/1/25/email">Email to a friend</a>
					</li>
		<li><a onclick="_gaq.push(['_trackEvent', 'order reprints', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=738&doi=10.1186/s13063-014-0542-8&volume=16&issue=1&title=The+FOCUS+trial%3A+cognitive+remediation+plus+standard+treatment+versus+standard+treatment+for+patients+at+ultra-high+risk+for+psychosis%3A+study+protocol+for+a+randomised+controlled+trial&author_name=Louise B Glenthøj&start_page=1&end_page=10">Order reprints</a></li>
		<li>
						<a onclick="_gaq.push(['_trackEvent', 'post a comment', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/16/1/25/postcomment">Post a comment</a>
					</li>			
		<ul id="download-to-links">
			<a class="downloadto_title btn" href="#"><span class="icon">&nbsp;</span>Download to ...</a>
			
			<ul id="downloadto" class="iconlist hidebeforeload" style="display: none;">
				<li>
					<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F25" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/25', 1, true]);"><span class="share-icons papers"></span>Papers</a>
				</li>
				<li>
					<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/25" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/25', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
				</li>
			</ul>
		</ul>
		
		<ul id="mobile-downloadto" class="iconlist">
		
		<h6>Download to ...</h6>
			<li>
				<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F25" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/25', 1, true]);"><span class="share-icons papers"></span>Papers</a>
			</li>
			
			<li>
				<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/25" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/25', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
		</ul>

		
	</ul>
		




<h5>Share this article</h5>
<ul id="social-networking-links">
	<li>
	<div class="fb-like" onclick="_gaq.push(['_trackEvent', 'Facebook Recommend', 'Article Sidebar', '/content/16/1/25', 1, true]);" data-href="http://www.trialsjournal.com/content/16/1/25" data-send="false" data-layout="button_count" data-width="100" data-show-faces="false" data-action="recommend"></div>
	</li>
	<li>
		<a onclick="_gaq.push(['_trackEvent', 'Share Twitter Recommend', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://twitter.com/share" data-url="http://www.trialsjournal.com/content/16/1/25" data-counturl="http://www.trialsjournal.com/content/16/1/25" data-hashtags="trials
" data-text="The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial" class="twitter-share-button">Tweet</a>
	</li>
	<li>
			<g:plusone size="medium" width="100"></g:plusone>
	</li>

        <li>
        <wb:share-button onclick="_gaq.push(['_trackEvent', 'Recommend Google plus', 'Article Sidebar', '/content/16/1/25', 1, true]);" addition="number" type="button" ralateUid="2216240737" title="The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial http://www.trialsjournal.com/content/16/1/25"></wb:share-button>
    </li>
    
		<a class="sharethis_title btn" href="#"><span class="icon">&nbsp;</span>More options...</a>
	<ul class="iconlist hidebeforeload" id="sharethis">
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'citeu Like', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://www.citeulike.org/posturl?url=http://www.trialsjournal.com/content/16/1/25"><span class="share-icons citeulike"></span>Citeulike</a>
			</li>
				<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Linkedin', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://www.linkedin.com/shareArticle?mini=true&url=%26%2335%3Btrials%0D%0AThe%20FOCUS%20trial%3A%20cognitive%20remediation%20plus%20standard%20treatment%20versus%20standard%20treatment%20for%20patients%20at%20ultra-high%20risk%20for%20psychosis%3A%20study%20protocol%20for%20a%20randomised%20controlled%20trial%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F25&title=The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial"><span class="share-icons linkedin"></span>LinkedIn</a>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share delicious', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://del.icio.us/post?url=http://www.trialsjournal.com/content/16/1/25&title=The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial"><span class="share-icons delicious"></span>Del.icio.us</a>
	</li>
			<li>
				<a onclick="_gaq.push(['_trackEvent', 'Share via email', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="/content/16/1/25/email"><span class="share-icons email"></span>Email</a>
	</li>
			<li>
				<a onclick="target="_blank" onclick="_gaq.push(['_trackEvent', 'Share facebook', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://www.facebook.com/sharer.php?u=http://www.trialsjournal.com/content/16/1/25"><span class="share-icons facebook"></span>Facebook</a>
	</li>
	<li class="gp">
			<div class="googlehider mobile-hide"> 
				<div class="g-plusone" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus mobile-hide"></span>
				<div class="googlehider2 mobile-hide"> 
				<div class="g-plusone mobile-hide" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus"></span>
				<span class="gp-link"><a  onclick="_gaq.push(['_trackEvent', 'Share google plus', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="#">Google+</a></span>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Mandeley', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/25"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
			<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share twitter icon', 'Article Sidebar', '/content/16/1/25', 1, true]);" href="http://twitter.com/?status=The%20FOCUS%20trial%3A%20cognitive%20remediation%20plus%20standard%20treatment%20versus%20standard%20treatment%20for%20patients%20at%20ultra-high%20risk%20for%20psychosis%3A%20study%20protocol%20for%20a%20randomised%20controlled%20trial%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F25+%23trials
"><span class="share-icons twitter"></span>Twitter</a>
			</li>

			<li><a href="http://www.reddit.com/submit" onclick="window.location = 'http://www.reddit.com/submit?url=http://www.trialsjournal.com/content/16/1/25'; return false"> <span class="share-icons reddit"></span>Reddit</a>
    </li>






		</ul>
</ul>

    </div>

    
  
        
                
        


















                                                                                
	

	    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="signup-to-etoc" class="button-collection-margins block mobile-border-bottom">	
					<h3>Email updates</h3>
			<p id="receive_issue_alerts_journal_updates_text">Keep up to date with the latest news and content from Trials and BioMed Central.</p>
			
				
<form  id="articleSignupForUpdates"  method="post" action="/signuptoupdates.html">
	<div id="message-box"></div>
    <fieldset class="block-form">
        <input type="text" name="emailAddress" onblur="javascript: if (this.value == '') { this.value = 'email address'; }" onfocus="javascript: if (this.value == 'email address') { this.value = ''; }" value="email address"  class="text " id="email" />
        <input value="" type="hidden" name="returnUrl" id="returnUrl" />
        <input value="xniche-trials" type="hidden" name="listName" id="listName" />
        <input value="Trials" type="hidden" name="journalName" id="journalName" />
        <button onclick="_gaq.push('_trackEvent', 'Signup', 'Signup for Email updates', "Trials");" class="w74 right" type="submit" onmouseover="this.className='w74 hover right'" onmouseout="this.className='w74 right'" value="Sign up">Sign up</button>
    </fieldset>
</form>	
</div>

	


			<div id="advert-offset">
    					
		<dl class="google-ad  ">
	<dt class="hide">
				
					<a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
			</dt>
		<dd>

		<!-- OAS AD 'Right3' begin -->
		<script type="text/javascript">
		OAS_AD('Right3');

		</script>
		<!-- OAS AD 'Right3' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad  noscript">  
    <dt class="hide"><a href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/014/0542/8/15998996717@Right3?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/014/0542/8/19598879109@Right3?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
					</div>
	

	
</div>
		<div class="mobile-sidebar-gradient top"></div>
		<div class="mobile-sidebar-gradient bottom"></div>
	</div>

</div>








 </div>
<div class="rounded custom white article full-text">
<div class="wrap-inner content">
    <div class="padded-inner">            


    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="topmatter">
	


	   






 
  



				<a href="/about/access"><img alt="Open Access" src="/images/articles/openaccess-large.png" class="access mr15"/></a>
					<span class="articletype">Study protocol</span>

<h1>The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial</h1>
        
			<div class="multipleins">
		
	<p class="authors">
        																																																																																																																																																																																																																																																																																																																																																																         <strong>Louise B Glenthøj</strong><sup><a href="/content/16/1/25/#ins1">1</a></sup><sup><a href="/content/16/1/25/#ins2">2</a></sup><sup>&#42;</sup>, <strong>Birgitte Fagerlund</strong><sup><a href="/content/16/1/25/#ins2">2</a></sup><sup><a href="/content/16/1/25/#ins3">3</a></sup>, <strong>Lasse Randers</strong><sup><a href="/content/16/1/25/#ins1">1</a></sup><sup><a href="/content/16/1/25/#ins2">2</a></sup>, <strong>Carsten R Hjorthøj</strong><sup><a href="/content/16/1/25/#ins1">1</a></sup>, <strong>Christina Wenneberg</strong><sup><a href="/content/16/1/25/#ins1">1</a></sup><sup><a href="/content/16/1/25/#ins2">2</a></sup>, <strong>Kristine Krakauer</strong><sup><a href="/content/16/1/25/#ins1">1</a></sup><sup><a href="/content/16/1/25/#ins2">2</a></sup>, <strong>Astrid Vosgerau</strong><sup><a href="/content/16/1/25/#ins1">1</a></sup><sup><a href="/content/16/1/25/#ins4">4</a></sup>, <strong>Christian Gluud</strong><sup><a href="/content/16/1/25/#ins5">5</a></sup>, <strong>Alice Medalia</strong><sup><a href="/content/16/1/25/#ins6">6</a></sup>, <strong>David L Roberts</strong><sup><a href="/content/16/1/25/#ins7">7</a></sup> and <strong>Merete Nordentoft</strong><sup><a href="/content/16/1/25/#ins1">1</a></sup><sup><a href="/content/16/1/25/#ins2">2</a></sup>	</p>
	
				<div id="affiliations">
		<div class="module gray  inner">
<div class="module-inner padded-inner">
		<ul>
			<li>                        
                                                                                                                                                    		<p class="authors" >
							<span>*</span>
									 Corresponding author:										            Louise B Glenthøj <a href='mailto:louise.birkedal.glenthoej@regionh.dk'>louise.birkedal.glenthoej@regionh.dk</a>    					</p>
      
</li>
			
                                                                                                                                                                                                                                                                                                                                    		</ul>

		
		 <p class="options"><a class="affiliations-toggle" href="#"><i class="arrow"></i>Author Affiliations</a></p>            <section> 
						<div class="collapsible-content">
							
				<div id="ins_container" style="display: block;">
										    						    <p >
						        <sup id="ins1">1</sup>                                Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, DK-2400, Denmark
                            </p>
																    						    <p >
						        <sup id="ins2">2</sup>                                Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Glostrup, DK-2600, Denmark
                            </p>
																    						    <p >
						        <sup id="ins3">3</sup>                                Centre for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Centre Glostrup, Copenhagen University Hospital, Glostrup, DK-2600, Denmark
                            </p>
																    						    <p >
						        <sup id="ins4">4</sup>                                Centre for Rehabilitation for Brain Injury, Copenhagen, DK-2300, Denmark
                            </p>
																    						    <p >
						        <sup id="ins5">5</sup>                                Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DK-2100, Denmark
                            </p>
																    						    <p >
						        <sup id="ins6">6</sup>                                Columbia University Medical Center, New York 10032, NY, USA
                            </p>
																    						    <p >
						        <sup id="ins7">7</sup>                                Department of Psychiatry, Division of Schizophrenia and Related Disorders, University of Texas Health Science Center, San Antonio 78229, TX, USA
                            </p>
																
				</div>
										<p id="authoremails">            For all author emails, please <a href="/logon">log on</a>.
    </p>
						</div>
			</section>
				</div>
</div>
		</div>
	  </div>

            <section class="cit">
                        <div class="collapsible-content">
        <p><em>Trials</em> 2015, <strong>16</strong>:25&nbsp;
			<span class="pseudotab">doi:10.1186/s13063-014-0542-8</span></p>
	    				    
    
        
                
		<p>The electronic version of this article is the complete one and can be found online at: <a href="http://www.trialsjournal.com/content/16/1/25">http://www.trialsjournal.com/content/16/1/25</a></p>
		<br/>
                    <table cellspacing="0" cellpadding="0">
        <tbody>
        <tr><td>Received:</td><td>3 October 2014</td></tr>                <tr><td>Accepted:</td><td>23 December 2014</td></tr>        <tr><td>Published:</td><td>27 January 2015</td></tr>        </tbody>
        </table>
    		<!--<br/>-->
		<div  style="line-height:140%">
        <p>
            &copy; 2015 Glenthøj et al.; licensee BioMed Central. <br />
        </p>
					<p>
				This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href='http://creativecommons.org/licenses/by/4.0'>http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
			</p>
		    	</div>
	</section>

</div>
<div id="article-body">
    <section><a name="abs"></a><h3>Abstract</h3>
   <div class="collapsible-content">
      <h4>Background</h4>
      <p style="line-height:160%">Cognitive deficits are a distinct feature among people at ultra-high risk (UHR) for
         psychosis and pose a barrier to functional recovery. Insufficient evidence exists
         on how to ameliorate these cognitive deficits in patients at UHR for psychosis and
         hence improve daily living and quality of life. The aim of the trial is to investigate
         whether cognitive remediation can improve cognitive and psychosocial function in patients
         at UHR for psychosis.
      </p>
      <h4>Methods</h4>
      <p style="line-height:160%">The FOCUS trial (Function and Overall Cognition in Ultra-high risk States) is a randomised,
         parallel group, observer-blinded clinical trial enrolling 126 patients meeting the
         standardised criteria of being at UHR for psychosis. Patients are recruited from psychiatric
         in- and outpatient facilities in the Copenhagen catchment area. Patients are randomised
         to one of the two treatment arms: cognitive remediation plus standard treatment versus
         standard treatment. The cognitive remediation consists of 24 weekly group-based and
         manualised sessions targeting neurocognition and social cognition. In addition to
         the group sessions, the patients will be offered 12 individual sessions aiming at
         maximising the transfer of the effects of the cognitive training to their everyday
         lives. Follow-up assessments will be conducted at 6 and 12 months after randomisation.
         The primary outcome is the composite score on the Brief Assessment of Cognition in
         Schizophrenia at cessation of treatment after 6 months. Secondary outcomes are social
         and daily functioning, psychosis-like symptoms, negative symptomatology, and depressive
         symptomatology as measured with the Personal and Social Performance Scale, Brief Psychiatric
         Rating Scale-Expanded Version, Scale for the Assessment of Negative Symptoms, and
         the Montgomery-Åsberg Depression Rating Scale.
      </p>
      <h4>Discussion</h4>
      <p style="line-height:160%">This is the first trial to evaluate the effects of neurocognitive and social cognitive
         remediation in UHR patients. The FOCUS trial results will provide evidence on the
         effect of targeted and comprehensive cognitive rehabilitation on cognition, daily
         living, and symptomatology as well as long-term outcome in preventing transition to
         psychosis in UHR patients.
      </p>
      <h4>Trial registration</h4>
      <p style="line-height:160%">ClinicalTrials.gov <a href="NCT 02098408">NCT 02098408</a> <a href="http://www.webcitation.org/query.php?url=NCT 02098408&amp;refdoi=10.1186/s13063-014-0542-8" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a>. Date of registration 18 March 2014.
      </p>
   </div>
</section><span id="keywords">
   <h5 class="inline">Keywords: </h5>At-risk mental state; Ultra-high risk for psychosis; Prodromal schizophrenia; Prodromal intervention; Cognitive remediation; Cognitive training; Social cognitive training; Neurocognitive training</span><section><a name="sec1"></a><h3>Background</h3>
   <div class="collapsible-content">
      <h4>The prodromal phase of schizophrenia and other psychotic disorders</h4>
      <p style="line-height:160%">Schizophrenia is a debilitating disorder with a point prevalence of 0.6% <a name="d73027e254"></a>[<a onclick="LoadInParent('#B1'); return false;" href="#B1">1</a>]. The construct of the ultra-high-risk (UHR) state for schizophrenia and other psychotic
         disorders captures the putative prodromal phase of psychosis, which is seen as a forerunner
         of frank psychosis. Patients in this UHR state present discrete yet identifiable psychotic
         symptoms. Intervention studies targeting the UHR state for psychosis have increased
         during the last decade <a name="d73027e258"></a>[<a onclick="LoadInParent('#B2'); return false;" href="#B2">2</a>]. Potentially, such interventions could avoid, ameliorate, or delay progression to
         psychosis. Furthermore, initiating appropriate treatment as early as possible has
         the potential to improve both the clinical and functional outcomes of patients.
      </p>
      <p style="line-height:160%">The most recent meta-analysis on prodromal intervention in psychosis assessed 10 randomised
         clinical trials aiming at preventing psychosis <a name="d73027e264"></a>[<a onclick="LoadInParent('#B3'); return false;" href="#B3">3</a>]. The intervention strategies in these trials encompass antipsychotic medication,
         omega-3 fatty acids, psychosocial, and cognitive behavioural interventions and integrative
         therapy <a name="d73027e268"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>]-<a name="d73027e272"></a>[<a onclick="LoadInParent('#B13'); return false;" href="#B13">13</a>]. The results from these trials are promising, but evidence is still too scarce to
         be conclusive. None of the studies on prodromal intervention have explored the potential
         effects of extensive cognitive remediation on improving cognitive and psychosocial
         functioning in prodromal patients or the potential to prevent transition to psychosis.
      </p>
      <h4>Cognitive dysfunctions and cognitive remediation in schizophrenia</h4>
      <p style="line-height:160%">It is well known that impairments in cognition are characteristic and pervasive in
         schizophrenia and significantly influence the functional outcome <a name="d73027e282"></a>[<a onclick="LoadInParent('#B14'); return false;" href="#B14">14</a>]-<a name="d73027e286"></a>[<a onclick="LoadInParent('#B16'); return false;" href="#B16">16</a>]. The cognitive and the associated functional impairments cause patients with schizophrenia
         to experience disturbances in areas such as independent living, social relationships,
         and educational attainment <a name="d73027e290"></a>[<a onclick="LoadInParent('#B15'); return false;" href="#B15">15</a>],<a name="d73027e294"></a>[<a onclick="LoadInParent('#B17'); return false;" href="#B17">17</a>] and are a strong predictor of response to psychiatric rehabilitation <a name="d73027e298"></a>[<a onclick="LoadInParent('#B18'); return false;" href="#B18">18</a>].
      </p>
      <p style="line-height:160%">Cognition encompasses neurocognitive and social cognitive processes, which are regarded
         as two distinct but interrelated domains <a name="d73027e304"></a>[<a onclick="LoadInParent('#B19'); return false;" href="#B19">19</a>]. Neurocognition can be defined as “processes of linking and appraising information.
         It includes abilities like speed of processing, attention, verbal and visual learning
         and memory, working memory as well as reasoning and problem solving” <a name="d73027e308"></a>[<a onclick="LoadInParent('#B20'); return false;" href="#B20">20</a>], whereas social cognition can be defined as “the mental operations that underlie
         social interactions, including perceiving, interpreting, and generating responses
         to the intentions, dispositions, and behaviours of others” <a name="d73027e312"></a>[<a onclick="LoadInParent('#B21'); return false;" href="#B21">21</a>]. It is hypothesised that social cognition acts as a mediator between neurocognition
         and functional outcome. Evidence for this hypothesis has been found in several studies
         <a name="d73027e316"></a>[<a onclick="LoadInParent('#B20'); return false;" href="#B20">20</a>],<a name="d73027e320"></a>[<a onclick="LoadInParent('#B22'); return false;" href="#B22">22</a>]-<a name="d73027e325"></a>[<a onclick="LoadInParent('#B27'); return false;" href="#B27">27</a>]. These findings imply that social cognition is proximal to the patients’ everyday
         functioning. In this context social cognition can be seen as critical for the daily
         functioning of the patients (e.g., community functioning, interpersonal relationships,
         and ultimately quality of life) <a name="d73027e329"></a>[<a onclick="LoadInParent('#B28'); return false;" href="#B28">28</a>]. Building on this rationale we decided to target both neurocognition and social cognition
         in our trial.
      </p>
      <p style="line-height:160%">A promising method to alleviate cognitive deficits is using cognitive remediation
         (CR). It can be defined as “a behavioural training based intervention that aims to
         improve cognitive processes (attention, memory, executive function, social cognition
         or metacognition) with the goal of durability and generalization” <a name="d73027e335"></a>[<a onclick="LoadInParent('#B29'); return false;" href="#B29">29</a>]. In the most recent meta-analysis of CR in schizophrenia, Wykes et al. reviewed 40
         trials. The effect of CR on cognition, functioning, and symptoms was assessed post-treatment
         and at follow-up. They demonstrated a significant positive effect in most cognitive
         domains [global cognition effect size 0.45 with 95% confidence interval (CI) = 0.31-0.59]
         and on functional outcomes (effect size 0.42 with 95% CI = 0.22-0.62). The effect
         appears to be durable (effect size 0.43 with 95% CI = 0.18-0.67). It is noted that
         the impact of CR on functional outcomes was significantly greater in studies also
         providing psychiatric rehabilitation <a name="d73027e339"></a>[<a onclick="LoadInParent('#B29'); return false;" href="#B29">29</a>]. This leads to the conclusion that CR seems an important and beneficial target of
         intervention in people with schizophrenia. Research indicates that CR is also effective
         in other severe mental illnesses <a name="d73027e343"></a>[<a onclick="LoadInParent('#B30'); return false;" href="#B30">30</a>],<a name="d73027e347"></a>[<a onclick="LoadInParent('#B31'); return false;" href="#B31">31</a>].
      </p>
      <h4>Cognitive dysfunctions and cognitive remediation among people at ultra-high risk for
         psychosis
      </h4>
      <p style="line-height:160%">A clinical staging model of the cognitive deficits in schizophrenia has been proposed.
         It suggests that there is a cognitive decline between early stages of the illness,
         implying that the cognitive deficits become increasingly severe as the illness develops
         <a name="d73027e357"></a>[<a onclick="LoadInParent('#B32'); return false;" href="#B32">32</a>]. Most studies favour a neurodevelopmental model suggesting that the cognitive deficits
         are already established before illness onset and remain mostly stable during the illness
         <a name="d73027e361"></a>[<a onclick="LoadInParent('#B33'); return false;" href="#B33">33</a>],<a name="d73027e365"></a>[<a onclick="LoadInParent('#B34'); return false;" href="#B34">34</a>].
      </p>
      <p style="line-height:160%">There is an increasing body of evidence demonstrating that patients in the UHR state
         show significant deficits in multiple cognitive domains <a name="d73027e371"></a>[<a onclick="LoadInParent('#B35'); return false;" href="#B35">35</a>]-<a name="d73027e375"></a>[<a onclick="LoadInParent('#B38'); return false;" href="#B38">38</a>]. In their meta-analysis on cognitive dysfunctions in the UHR state, Fusar-Poli et
         al. found cognitive deficits associated with the UHR state in attention, verbal fluency,
         visual and verbal memory, working memory, and executive functioning <a name="d73027e379"></a>[<a onclick="LoadInParent('#B35'); return false;" href="#B35">35</a>]. An area of cognition that also has been found to be impaired in the UHR state is
         social cognition, which appears to be closely related to functional outcome <a name="d73027e383"></a>[<a onclick="LoadInParent('#B22'); return false;" href="#B22">22</a>],<a name="d73027e387"></a>[<a onclick="LoadInParent('#B39'); return false;" href="#B39">39</a>]. Evidence shows that the cognitive deficits in UHR patients have a significant impact
         on their level of functioning <a name="d73027e392"></a>[<a onclick="LoadInParent('#B37'); return false;" href="#B37">37</a>],<a name="d73027e396"></a>[<a onclick="LoadInParent('#B40'); return false;" href="#B40">40</a>], an even greater impact than symptom severity <a name="d73027e400"></a>[<a onclick="LoadInParent('#B22'); return false;" href="#B22">22</a>],<a name="d73027e404"></a>[<a onclick="LoadInParent('#B37'); return false;" href="#B37">37</a>].
      </p>
      <p style="line-height:160%">Reviewing the literature in the electronic databases (PubMed, EMBASE, Clinical Trials.gov,
         and WHO Trial Portal) for studies related to the terms “cognitive remediation, prodromal
         psychosis, or ultra-high risk states” resulted in only two published studies that
         have examined the effect of CR on UHR patients. Bechdolf et al. offered CR as part
         of a broader integrated intervention programme <a name="d73027e410"></a>[<a onclick="LoadInParent('#B9'); return false;" href="#B9">9</a>]. They found a beneficial effect of the integrated intervention, but it was not possible
         to isolate the effect of the CR. A pilot study by Rauchensteiner et al. compared the
         effectiveness of CR in 10 UHR patients to that of CR in 16 patients with schizophrenia
         and found relatively greater improvements in cognitive functioning (improved long-term
         memory functions as well as attention) in the former group <a name="d73027e414"></a>[<a onclick="LoadInParent('#B41'); return false;" href="#B41">41</a>]. However, as the authors also state, this finding needs to be replicated in studies
         using larger sample sizes. Furthermore, the observational design generally hinders
         fair assessment of the benefits of interventions <a name="d73027e418"></a>[<a onclick="LoadInParent('#B42'); return false;" href="#B42">42</a>]. Of note, the two studies included short-term remediation programmes (10-12 sessions)
         without direct assessment of the effect on daily functioning. Accordingly, there is
         a need for randomised clinical trials that apply more extensive cognitive training
         on larger UHR samples.
      </p>
      <p style="line-height:160%">The aim of the FOCUS trial is to investigate to what extent CR may improve cognitive
         abilities and the associated psychosocial function in patients at UHR for psychosis.
         Bearing in mind the disabling consequences of cognitive deficits in schizophrenia
         and psychosis-like states, it seems vital to target these deficits to improve the
         everyday functioning of the patients. Knowing that the cognitive deficits manifest
         themselves in the UHR state, we expect that cognitive deficits may be even more amenable
         to treatment at this early stage of illness than what has previously been found at
         a more chronic stage <a name="d73027e424"></a>[<a onclick="LoadInParent('#B43'); return false;" href="#B43">43</a>],<a name="d73027e428"></a>[<a onclick="LoadInParent('#B44'); return false;" href="#B44">44</a>]. Accordingly, targeting cognitive dysfunctions in the prodromal phase of psychosis
         may be the optimal time to intervene.
      </p>
      <p style="line-height:160%">If a beneficial effect of CR on the cognitive and psychosocial dysfunctions in UHR
         patients is found, this would point to future randomised clinical trials and later
         potential implementation of CR in facilities offering early intervention in psychosis
         in order to enhance the ability of patients to function in their daily life.
      </p>
      <h4>Hypotheses</h4>
      <p style="line-height:160%">In the present study we will examine whether:</p>
      <p style="line-height:160%">1. Cognitive remediation therapy will be superior to standard treatment in improving
         cognitive functioning in UHR patients (null hypothesis: no difference between the
         two intervention groups).
      </p>
      <p style="line-height:160%">2. Cognitive remediation therapy will be superior to standard treatment in improving
         psychosocial functioning and clinical symptoms in UHR patients (null hypothesis: no
         difference between the two intervention groups).
      </p>
   </div>
</section>
<section><a name="sec2"></a><h3>Methods</h3>
   <div class="collapsible-content">
      <h4>Recruitment</h4>
      <p style="line-height:160%">The FOCUS trial is a randomised, blinded, parallel-group superiority clinical trial,
         enrolling a total of 126 help-seeking patients from in- and outpatient facilities
         in the catchment area of Copenhagen (Figure&nbsp;<a name="d73027e453"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/25/figure/F1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/25/figure/F1">1</a>). Patients meeting standardised ‘at-risk’ criteria based on the Comprehensive Assessment
         of At-Risk Mental States (CAARMS) <a name="d73027e457"></a>[<a onclick="LoadInParent('#B45'); return false;" href="#B45">45</a>] will be approached about participating in this clinical trial. Patients will be randomised
         (1:1) to intensive CR plus standard treatment versus standard treatment, as described
         in further detail in the section&nbsp;Interventions.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/25/figure/F1','F1',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/25/figure/F1"><img align="top" src="/content/figures/s13063-014-0542-8-1.gif" alt="thumbnail" class="thumbnail"><strong>Figure 1.</strong></a> <strong>Flowchart of the FOCUS trial.</strong></div></div>
      <h4>Inclusion criteria</h4>
      <p style="line-height:160%">Participants aged 18-40 years who provide written informed consent and fulfil criteria
         for being at UHR for psychosis (defined by one or more of the following):
      </p>
      <p style="line-height:160%"><strong>Vulnerability (Trait and State Risk Factor) Group:</strong> Individuals with a combination of a trait risk factor (schizotypal personality disorder
         or a family history of psychotic disorder in a first degree relative) and a significant
         deterioration in functioning or sustained low functioning during the past year.
      </p>
      <p style="line-height:160%"><strong>Attenuated Psychotic Symptoms (APS) Group:</strong> Individuals with sub-threshold (intensity or frequency) positive psychotic symptoms.
         The symptoms must have been present during the past year.
      </p>
      <p style="line-height:160%"><strong>Brief Limited Intermittent Psychotic Symptoms (BLIPS) Group:</strong> Individuals with a recent history of frank psychotic symptoms that resolved spontaneously
         (without antipsychotic medication) within 1 week. The symptoms must have been present
         during the past year.
      </p>
      <h4>Exclusion criteria</h4>
      <p style="line-height:160%">Exclusion criteria are: a past history of a treated or untreated psychotic episode
         of 1 week’s duration or longer, psychiatric symptoms that are explained by a physical
         illness with psychotropic effect or acute intoxication (e.g., cannabis use), a diagnosis
         of a serious developmental disorder (e.g., Asperger’s syndrome), currently receiving
         methylphenidate, or rejects providing informed consent.
      </p>
      <p style="line-height:160%">An exit criterion is transition to psychosis. Participants who convert to psychosis
         will be assessed with the 12-month assessment battery.
      </p>
      <h4>Interventions</h4>
      <h4>Cognitive remediation (CR) in the experimental group</h4>
      <p style="line-height:160%">The CR is conducted in a group setting using both computerised exercises and group
         exercises. Patients assigned to the experimental intervention group will receive 2
         h of CR (1 h of neurocognitive training and 1 h of social cognitive training) once
         a week for a total of 24 weeks. The training is done in an open group format. In addition
         to the group training there will be a total of 12 individual sessions of about 50
         min aiming at maximising the bridging of the cognitive training to the everyday functioning
         of the patients, as well as working with individual goals.
      </p>
      <p style="line-height:160%">The CR is delivered by a cognitive specialist in collaboration with a psychology student
         with knowledge of cognitive psychology. There will be a maximum of eight participants
         in each group; thus the therapist-to-patient ratio will be 1:4 or less.
      </p>
      <p style="line-height:160%">If a patient meets the exit criterion “transition to psychosis”, he or she will be
         excluded from the intervention but still participate in assessments and statistical
         analyses, in accordance with the intention-to-treat principle.
      </p>
      <h4>The neurocognitive training</h4>
      <p style="line-height:160%">The neurocognitive remediation will be done by using the Neuropsychological Educational
         Approach to Cognitive Remediation (NEAR) <a name="d73027e519"></a>[<a onclick="LoadInParent('#B46'); return false;" href="#B46">46</a>],<a name="d73027e523"></a>[<a onclick="LoadInParent('#B47'); return false;" href="#B47">47</a>]. NEAR is an evidence-based approach that focuses on aspects such as learning and
         motivation when doing CR. The patients will receive individual neurocognitive training
         on a computer followed by a group discussion that aims at relating the cognitive exercises
         to real-world activities. In addition to the group training the patients are instructed
         to do at least 1 h per week of computerised training at home.
      </p>
      <h4>The social cognitive training</h4>
      <p style="line-height:160%">The overall aim of the social cognitive training is to enhance the skills that enable
         the patients to understand the thoughts and intentions of others and to respond adequately
         in social situations. The social cognitive training will be by use of the Social Cognition
         and Interaction Training (SCIT) manual developed by Roberts et al. <a name="d73027e533"></a>[<a onclick="LoadInParent('#B48'); return false;" href="#B48">48</a>], which takes the form of group psychotherapy and skills training. It addresses several
         of the key social cognitive domains, comprising intolerance of ambiguity, attributional
         biases in explaining negative events, theory of mind (ToM), and emotion perception
         abnormalities<em>.</em> It is the assumption that these social cognitive skills hinder adequate social behaviour
         in schizophrenia and psychosis-like states.
      </p>
      <h4>Individual sessions</h4>
      <p style="line-height:160%">The individual sessions serve the purpose of maximising the transfer of the effect
         of the group training to the daily lives of the patients. The individual sessions
         are embedded in cognitive behavioural therapy (CBT) and use core CBT techniques such
         as goal setting, modifying distorted thinking, problem solving, and role-play. The
         content of the individual sessions will be tailored to fit the specific problems of
         the patient. The sessions will follow a manual that frames the sessions. However,
         it must be taken into account that the sessions cannot be completely manualised as
         the therapist approach and CBT techniques used will depend on the individual problem.
      </p>
      <h4>Fidelity to treatment manual</h4>
      <p style="line-height:160%">The intervention is manual-based, which improves standardisation of the treatment.
         David Roberts, co-author of the SCIT manual <a name="d73027e552"></a>[<a onclick="LoadInParent('#B48'); return false;" href="#B48">48</a>], has given a training course at the Mental Health Centre Copenhagen to ensure a proper
         understanding and use of the SCIT manual as well as adherence to it. The therapists
         will be offered bi-weekly Skype supervision from Dr Roberts throughout the trial.
      </p>
      <p style="line-height:160%">A selected number of group sessions will be videotaped and used to rate adherence
         to the treatment manual by independent raters. The adherence will be rated by use
         of the SCIT Fidelity Scale (appendix in the SCIT manual) <a name="d73027e558"></a>[<a onclick="LoadInParent('#B48'); return false;" href="#B48">48</a>].
      </p>
      <h4>Standard intervention in the experimental group</h4>
      <p style="line-height:160%">The standard intervention in the experimental group is planned to be similar to the
         standard intervention in the control group (see description below).
      </p>
      <h4>Standard interventions in the control group</h4>
      <p style="line-height:160%">Patients allocated to the control group are free to choose whatever standard treatment
         they are offered by the clinicians managing their treatment. Usually standard treatment
         consists of a somewhat regular contact to health professionals in the in- and outpatient
         facilities in the capital region of Denmark (e.g., community psychiatric centres or
         private specialists in psychiatry). It involves monitoring of psychopharmacological
         treatment and different kinds of supportive counselling, e.g., concerning their psychiatric
         symptoms, relating to functional domains, or a more regular psychotherapeutic intervention
         depending on the nature of the health-service managing their treatment. In contrast
         to the intervention group, standard treatment does not involve specific cognitive
         training.
      </p>
      <p style="line-height:160%">The standard treatment provided to both the experimental and control group will be
         carefully registered in retrospect at the end of the trial by an independent blinded
         assessor using a checklist comprising items such as use of medication, psychological
         interventions, number of sessions, and therapist skills.
      </p>
      <h4>Medications</h4>
      <p style="line-height:160%">Patients in both treatment groups are allowed to receive medication. In case an antipsychotic-naïve
         patient develops psychosis during the trial, this will be reported to the health service
         managing the treatment in order for them to initiate antipsychotic treatment.
      </p>
      <h4>Assessments</h4>
      <p style="line-height:160%">Assessments will be conducted at baseline, prior to randomisation, as information
         from the baseline assessment is used to perform stratified randomisation and validate
         inclusion and exclusion criteria. The assessments will be performed at cessation of
         treatment 6 months after randomisation and at follow-up 12 months after randomisation.
      </p>
      <h4>Diagnosis</h4>
      <p style="line-height:160%">The Comprehensive Assessment of At-Risk Mental States (CAARMS) <a name="d73027e594"></a>[<a onclick="LoadInParent('#B45'); return false;" href="#B45">45</a>] is used to classify patients as being at UHR for psychosis as well as assessing for
         transition to psychosis during the trial period. The Structured Clinical Interview
         for DSM-IV (SCID) <a name="d73027e598"></a>[<a onclick="LoadInParent('#B49'); return false;" href="#B49">49</a>],<a name="d73027e602"></a>[<a onclick="LoadInParent('#B50'); return false;" href="#B50">50</a>] will be used to assess diagnosis.
      </p>
      <p style="line-height:160%">The CAARMS is a validated instrument showing good to excellent reliability <a name="d73027e608"></a>[<a onclick="LoadInParent('#B45'); return false;" href="#B45">45</a>].
      </p>
      <h4>Neurocognitive function</h4>
      <p style="line-height:160%">Neurocognitive function will be assessed using a comprehensive test battery including
         the Danish Adult Reading Test (DART), a Danish adaptation of the National Adult Reading
         Test <a name="d73027e618"></a>[<a onclick="LoadInParent('#B51'); return false;" href="#B51">51</a>]; four subtests from the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III)
         <a name="d73027e622"></a>[<a onclick="LoadInParent('#B51'); return false;" href="#B51">51</a>]; Vocabulary, Similarities, Block Design and Matrix Reasoning; the Brief Assessment
         of Cognition in Schizophrenia (BACS) battery <a name="d73027e626"></a>[<a onclick="LoadInParent('#B52'); return false;" href="#B52">52</a>]; and the Behavior Rating Inventory of Executive Functions-Adult Version (BRIEF-A)
         <a name="d73027e630"></a>[<a onclick="LoadInParent('#B53'); return false;" href="#B53">53</a>]. Furthermore, patients will undergo the following computerised tests from the Cambridge
         Neuropsychological Test Automated Battery (CANTAB) <a name="d73027e634"></a>[<a onclick="LoadInParent('#B51'); return false;" href="#B51">51</a>]: Motor Screening Test, Spatial Span, Spatial Working Memory, Emotion Recognition
         Task, Stockings of Cambridge, IED Set Shifting Test, Paired Associate Learning, 5-Choice
         Serial Reaction Time, and Rapid Visual Information Processing.
      </p>
      <p style="line-height:160%">The BACS is specifically designed to detect cognitive changes in response to treatment.
         The validity and reliability properties of the BACS have been established in patients
         with schizophrenia and healthy controls, and the BACS composite score has proven high
         test-retest reliability, increasing the likelihood of detecting a treatment-related
         effect <a name="d73027e640"></a>[<a onclick="LoadInParent('#B52'); return false;" href="#B52">52</a>],<a name="d73027e644"></a>[<a onclick="LoadInParent('#B54'); return false;" href="#B54">54</a>],<a name="d73027e648"></a>[<a onclick="LoadInParent('#B55'); return false;" href="#B55">55</a>].
      </p>
      <p style="line-height:160%">The tests included in the CANTAB battery have proven high validity <a name="d73027e654"></a>[<a onclick="LoadInParent('#B56'); return false;" href="#B56">56</a>],<a name="d73027e658"></a>[<a onclick="LoadInParent('#B57'); return false;" href="#B57">57</a>]. The reliability of the CANTAB tests varies between individual tests. High reliability
         (<em>r</em> &gt; 0.8) has been shown on measures of visual processing, e.g., the Paired Associates
         Learning task, while lower reliability has been found particularly on measures of
         executive functions, e.g., sub-measures of the IED Set Shifting Task <a name="d73027e665"></a>[<a onclick="LoadInParent('#B58'); return false;" href="#B58">58</a>]. This lower reliability of tests that assess executive functions is very difficult
         to avoid because of the necessary task novelty involved in assessing executive processing
         <a name="d73027e669"></a>[<a onclick="LoadInParent('#B58'); return false;" href="#B58">58</a>].
      </p>
      <h4>Social cognitive function</h4>
      <p style="line-height:160%">Social cognitive function will be measured with The Awareness of Social Inference
         Test (TASIT) <a name="d73027e679"></a>[<a onclick="LoadInParent('#B59'); return false;" href="#B59">59</a>], the High-Risk Social Challenge task (HiSoC) <a name="d73027e683"></a>[<a onclick="LoadInParent('#B60'); return false;" href="#B60">60</a>], the Social Cognition Screening Questionnaire (SCSQ) <a name="d73027e687"></a>[<a onclick="LoadInParent('#B61'); return false;" href="#B61">61</a>], and Social Responsiveness Scale (SRS) <a name="d73027e691"></a>[<a onclick="LoadInParent('#B62'); return false;" href="#B62">62</a>].
      </p>
      <h4>Symptomatology</h4>
      <p style="line-height:160%">General symptomatology, negative, depressive, and manic symptomatology will be measured
         with the Brief Psychiatric Rating Scale Expanded Version (BPRS-E) <a name="d73027e701"></a>[<a onclick="LoadInParent('#B63'); return false;" href="#B63">63</a>], the Scale for the Assessment of Negative Symptoms (SANS) <a name="d73027e705"></a>[<a onclick="LoadInParent('#B64'); return false;" href="#B64">64</a>],<a name="d73027e709"></a>[<a onclick="LoadInParent('#B65'); return false;" href="#B65">65</a>], the Montgomery-Åsberg Depression Rating Scale (MADRS) <a name="d73027e713"></a>[<a onclick="LoadInParent('#B66'); return false;" href="#B66">66</a>], the Young Mania Rating Scale (YMRS) <a name="d73027e717"></a>[<a onclick="LoadInParent('#B67'); return false;" href="#B67">67</a>], and the Clinical Global Impression (CGI) <a name="d73027e722"></a>[<a onclick="LoadInParent('#B68'); return false;" href="#B68">68</a>]. Nine cognitive-perceptive basic symptoms from the Schizophrenia Prediction/Proneness
         Instrument-Adult Version (SPI-A) <a name="d73027e726"></a>[<a onclick="LoadInParent('#B69'); return false;" href="#B69">69</a>] will be used as a measure of subjectively experienced cognitive-perceptive symptoms.
      </p>
      <h4>Psychosocial function</h4>
      <p style="line-height:160%">Three measures will be included to assess psychosocial functioning: the Personal and
         Social Performance Scale (PSP) <a name="d73027e736"></a>[<a onclick="LoadInParent('#B70'); return false;" href="#B70">70</a>], Social and Occupational Functioning Assessment Scale (SOFAS) <a name="d73027e740"></a>[<a onclick="LoadInParent('#B71'); return false;" href="#B71">71</a>], and Global Functioning: Social and Role Scales <a name="d73027e744"></a>[<a onclick="LoadInParent('#B72'); return false;" href="#B72">72</a>].
      </p>
      <h4>Other assessment tools</h4>
      <p style="line-height:160%">Five other assessment tools will be used assessing family history, premorbid functioning,
         substance use, and quality of life. An abbreviated version of the Family Interview
         for Genetic Studies (FIGS) Family History Index (FHI) (Maxwell M.E: Family interview
         for genetic studies (FIGS); Manual for FIGS. Unpublished manuscript) is used to assess
         family history of psychiatric disorder, the Premorbid Adjustment Scale (PAS) <a name="d73027e754"></a>[<a onclick="LoadInParent('#B73'); return false;" href="#B73">73</a>] assessing premorbid functioning level, Alcohol Smoking &amp; Substance Involvement Screening
         Test (ASSIST) (WHO ASSIST working group 2002 <a name="d73027e758"></a>[<a onclick="LoadInParent('#B74'); return false;" href="#B74">74</a>]) assessing substance use, and Quality of Life Scale (QOLS) <a name="d73027e762"></a>[<a onclick="LoadInParent('#B75'); return false;" href="#B75">75</a>] assessing the patients’ perceived quality of life. At cessation of treatment after
         6 months the patients’ satisfaction with the received treatment will be evaluated
         using the Client Satisfaction Questionnaire (CSQ) <a name="d73027e766"></a>[<a onclick="LoadInParent('#B76'); return false;" href="#B76">76</a>].
      </p>
      <h4>Adverse events</h4>
      <p style="line-height:160%">The participants’ well-being will be a primary focus during the trial. Accordingly,
         their safety will be monitored and accurately reported throughout the treatment period.
         CR is not known or expected to cause adverse events <a name="d73027e776"></a>[<a onclick="LoadInParent('#B77'); return false;" href="#B77">77</a>]; therefore, we do not expect any adverse events to occur. However, should an adverse
         event occur, it will be dealt with properly by the therapists in charge of the treatment.
         Using our outcome instruments we will investigate whether the FOCUS intervention causes
         nominally worse scores, which will be interpreted as a possible indication of harm.
      </p>
      <h4>Setting of assessment</h4>
      <p style="line-height:160%">All the assessments will take place at the Mental Health Centre Copenhagen. Most tests
         are assessed using paper and pencil with the exception of CANTAB, which is a computerised
         test battery, and the HiSoC test, which uses videotaping. The staff members performing
         the SCID interview are psychologists and medical doctors who have undergone a 4-day
         training course using the SCID diagnostic interview co-supervised by Dr Joseph Ventura.
      </p>
      <h4>Data management</h4>
      <p style="line-height:160%">All the data will be stored in locked cabinets at the Mental Health Centre Copenhagen
         in pseudo-anonymised form (i.e., identifiable only with project codes, which are stored
         separately from the project key identifying the codes). The data will be completely
         anonymised after publication of all results. The participants’ privacy will be protected
         by the Danish Data Protection Agency, which has approved the trial.
      </p>
      <p style="line-height:160%">Databases will be kept locally at the Mental Health Centre Copenhagen under blinded
         conditions (see Blinding).
      </p>
      <h4>Outcomes and sample size calculation</h4>
      <h4>Primary outcome</h4>
      <p style="line-height:160%">The primary outcome is overall cognitive function, measured with the BACS composite
         score 6 months after randomisation.
      </p>
      <h4>Sample size calculation</h4>
      <p style="line-height:160%">The sample size calculation is based on our primary outcome, a priori defined to be
         the between-group difference at 6 months on the BACS composite score. We consider
         a clinically relevant difference on this scale to correspond to a Cohen’s <em>d</em> of 0.50 (e.g., assuming a between-group difference of 3.0 and a pooled SD of 6.0)
         <a name="d73027e814"></a>[<a onclick="LoadInParent('#B29'); return false;" href="#B29">29</a>]. With a two-sided alpha of 0.05 and power of 80%, this will require 63 participants
         to be randomised to each of the two interventions.
      </p>
      <h4>Secondary outcomes and power calculations</h4>
      <p style="line-height:160%">The difference in global personal and social functioning 6 months after inclusion
         will be measured with the PSP. With 63 participants in each group, and assuming a
         pooled standard deviation of 10 points <a name="d73027e824"></a>[<a onclick="LoadInParent('#B72'); return false;" href="#B72">72</a>],<a name="d73027e828"></a>[<a onclick="LoadInParent('#B78'); return false;" href="#B78">78</a>]-<a name="d73027e832"></a>[<a onclick="LoadInParent('#B81'); return false;" href="#B81">81</a>], we will have more than 97% power to detect a difference of 7 points between the
         groups, which would be considered the minimal clinically relevant difference on this
         scale <a name="d73027e836"></a>[<a onclick="LoadInParent('#B82'); return false;" href="#B82">82</a>].
      </p>
      <p style="line-height:160%">The BPRS-E will be used to measure symptomatology (e.g., psychosis-like symptoms).
         The BPRS scale is expected to have a pooled standard deviation of 20.0 points <a name="d73027e842"></a>[<a onclick="LoadInParent('#B83'); return false;" href="#B83">83</a>]. Given a sample size of 63 per group and a two-sided alpha of 0.05, we have 80% power
         to detect a difference between the two groups of at least 10.06 points. Antipsychotic
         treatment and psychotherapeutic interventions have been shown to reduce BPRS by more
         than 12 points <a name="d73027e846"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>],<a name="d73027e850"></a>[<a onclick="LoadInParent('#B84'); return false;" href="#B84">84</a>], indicating that we have sufficient power to detect the minimally relevant difference
         on this secondary outcome.
      </p>
      <p style="line-height:160%">Negative symptomatology will be assessed using the SANS. The SANS scale is expected
         to have a pooled standard deviation of 13 points <a name="d73027e856"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>]. Given a sample size of 63 per group and a two-sided alpha of 0.05, we have 80% power
         to detect a difference between the two groups of at least 6.54 points. Treatments
         with cognitive and supportive therapy as well as risperidone have been shown to reduce
         SANS by more than 7 points <a name="d73027e860"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>]. This indicates that we have sufficient power to detect the minimally relevant difference
         of this secondary outcome.
      </p>
      <p style="line-height:160%">Depressive symptoms will be assessed using the MADRS. Data from a previous randomised
         clinical trial with UHR patients shows a SD of 9.56 points <a name="d73027e866"></a>[<a onclick="LoadInParent('#B6'); return false;" href="#B6">6</a>]. Allowing for larger variance in data we set a SD of 10 when calculating detectable
         differences. With our sample size of 63 per group and a two-sided alpha of 0.05, we
         have 80% power to detect a difference between the two groups of at least 5.03 points.
      </p>
      <h4>Exploratory outcomes</h4>
      <p style="line-height:160%">Exploratory outcomes will be transition to psychosis assessed by the CAARMS; symptomatology
         assessed by the CAARMS and SPI-A; and social cognition assessed by the ERT, TASIT,
         HiSoC, SCSQ, and SRS. Psychosocial function will be measured with the SOFAS and Global
         Functioning: Social and Role Scales. Additionally, the BRIEF-A will be used as a proxy
         measure of daily functioning. Patients perceived quality of life will be assessed
         with the QOLS, and lastly the number of participants experiencing adverse events will
         be recorded.
      </p>
      <h4>Randomisation</h4>
      <p style="line-height:160%">Randomisation will be centralised with a concealed randomisation sequence carried
         out by the Copenhagen Trial Unit (CTU). Randomisation will be stratified by current
         use of antipsychotic medication (yes/no) and the IQ score (≤100/&gt;100). Block size
         will be unknown to the investigators and clinicians.
      </p>
      <p style="line-height:160%">Signed informed consent will be obtained prior to randomisation. The randomisation
         is computerised and central. The blinded assessors will enter the participant’s data
         on a webpage hosted by the CTU. Thereafter, a computerised randomisation is performed,
         and an email is sent to an independent member at Mental Health Centre Copenhagen revealing
         to which intervention programme the participant has been allocated. The staff member
         then contacts the participant and informs him or her of the result of the randomisation.
         The randomised intervention allocation is concealed until the statistical analyses
         of resulting data have been completed.
      </p>
      <h4>Blinding</h4>
      <p style="line-height:160%">The patients and treatment providers will not be blinded. The blinding applies to
         researchers involved in assessments, data management, data analysis, and drawing outcome
         conclusions. For the follow-up interviews the patient is instructed in advance not
         to reveal what type of treatment was received.
      </p>
      <h4>Statistical analyses</h4>
      <p style="line-height:160%">The planned comparisons between the two groups on continuous outcomes will be carried
         out with a generalised linear model adjusted for stratification variables, potential
         baseline imbalances, and skewed attrition, with missing data handled by multiple imputations.
         As an important secondary assessment of this type of outcome, linear mixed model analyses
         with repeated measurements and an unstructured covariance matrix will assess the interaction
         term between time and intervention. For non-normally distributed continuous outcome
         measures, non-parametric analyses will be applied. For dichotomous outcomes, logistic
         regression will be applied, and for time to transition, Cox proportional hazards regression
         will be applied. All analyses will be according to the intention-to-treat principle,
         analysing all participants in the groups they were assigned to by randomisation. We
         expect to encounter missing data, and this will be handled with the linear mixed models
         and multiple imputations as appropriate. A blinded and independent statistician who
         has no contact to the trial participants will conduct the primary efficacy analyses.
      </p>
      <h4>Ethical consideration</h4>
      <p style="line-height:160%">The trial has obtained approval by the Regional Ethics Committee of Zealand (H-6-2013-015)
         and the Danish Data Protection Agency (RHP-2014-009-02670). The trial is registered
         at ClinicalTrial.gov as NCT 02098408. Positive as well as neutral and negative results
         of the trial will be published in international journals.
      </p>
      <p style="line-height:160%">The participants will receive information on the trial both verbally and in written
         form. Written informed consent will be obtained from each participant before inclusion
         in the trial. It is emphasised that participation in the trial is voluntary and that
         the participant can withdraw his or her consent at any time without consequences for
         treatment possibilities. We will upload depersonalised individual patient data to
         be used in meta-analyses on Zenodo via OpenAIRE (<a href="https://www.openaire.eu/">https://www.openaire.eu/</a> <a href="http://www.webcitation.org/query.php?url=https://www.openaire.eu/&amp;refdoi=10.1186/s13063-014-0542-8" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a>).
      </p>
   </div>
</section>
<section><a name="sec3"></a><h3>Discussion</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">There are several strengths in the design of the FOCUS trial. First, to our knowledge
         no other randomised clinical trial has assessed the effect of both neurocognitive
         and social cognitive remediation in a UHR population. Second, the CR has a primary
         focus on linking cognitive remediation to real-life improvements. Third, it is a large-scale
         trial. As UHR patients are difficult to attain, the sample size of 126 UHR patients
         makes it one of the biggest UHR intervention trials to date. Fourth, it employs observer-blinded
         assessment of outcomes with the intention to ensure that the outcome data are assessed
         without bias <a name="d73027e913"></a>[<a onclick="LoadInParent('#B85'); return false;" href="#B85">85</a>]. Moreover, data management, data analyses, and conclusions will be conducted and
         drawn blind to the intervention group. Fifth, assessing outcome at cessation of treatment
         after 6 months will allow evaluating the immediate effect of the CR, whereas the 12-month
         follow-up evaluates the long-term effects of the CR intervention. Sixth, the wide
         range of outcome estimates in the trial allows the opportunity to assess outcome in
         multiple areas of cognition, symptomatology, and adaptive functioning.
      </p>
      <p style="line-height:160%">The trial may have some limitations as to the best of our knowledge no published trial
         has investigated the effect of combining the SCIT treatment with a neurocognitive
         remediation programme. Hence, we lack knowledge on the feasibility of this approach.
         However, as stated in the Background section, evidence shows that both the neurocognitive
         and social cognitive domains are impaired in UHR patients. Therefore, it seems essential
         to try to target both domains. This is further supported by the hypothesis that social
         cognition acts as a mediator between neurocognition and real-world outcome. Furthermore,
         it seems highly effective to combine treatment modalities in CR <a name="d73027e919"></a>[<a onclick="LoadInParent('#B29'); return false;" href="#B29">29</a>],<a name="d73027e923"></a>[<a onclick="LoadInParent('#B86'); return false;" href="#B86">86</a>]. Another limitation is that the experimental intervention is an add-on to standard
         treatment. This design could potentially cause the problem of patients in the intervention
         group receiving less standard treatment as a result of participating in the trial.
      </p>
   </div>
</section>
<section><a name="sec4"></a><h3>Trial status</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">Trial initiation was April 2014. By November 2014, 19 patients had been randomised.</p>
   </div>
</section>
<section><a name="sec5"></a><h3>Abbreviations</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">CR: Cognitive remediation</p>
      <p style="line-height:160%">CTU: Copenhagen trial unit</p>
      <p style="line-height:160%">SCIT: Social cognition and interaction training</p>
      <p style="line-height:160%">RCT: Randomised clinical trial</p>
      <p style="line-height:160%">ToM: Theory of mind</p>
      <p style="line-height:160%">UHR: Ultra-high risk</p>
   </div>
</section>
<section><a name="sec6"></a><h3>Competing interests</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The authors declare that they have no competing interests.</p>
   </div>
</section>
<section><a name="sec7"></a><h3>Authors’ contributions</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">LBG, MN, BF, and LR conceived the trial. LBG and MN wrote the first draft of the protocol.
         CG participated in the design of the trial, writing the manuscript, and critical revision
         of the work. CW and KK participated in the design of the trial, writing the manuscript,
         and critical revision of the work and were involved in the data collection. BF, LR,
         and AV contributed with expertise in cognitive deficits and cognitive remediation
         and participated in the design of the trial, writing the manuscript, and critical
         revision of the work. AM and DR contributed with expertise in cognitive remediation
         and the design of the intervention, writing the manuscript, and critical revision
         of the work. CRH contributed with statistical expertise, writing the manuscript, and
         critical revision of the work. All authors read, improved, and approved the final
         manuscript.
      </p>
   </div>
</section>
<section><a name="ack"></a><h3>Acknowledgements</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">Funding for this trial was provided by Mental Health Services of the Capital Region
         of Denmark, the Research Fund of the Capital Region Denmark, and the Lundbeck Foundation
         Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS.
         The funding sources had no role in the design of this trial and will not have any
         role during its execution, analyses, interpretation of the data, or decision to submit
         results.
      </p>
      <p style="line-height:160%">The authors would like to thank Jens Richardt Møllegaard Jepsen (MSc Psychology, PhD)
         and Vibeke Fuglsang Bliksted (MSc Psychology, PhD) for their consultative expertise
         on social cognition during the design phase, Maria Galsgaard (BA Psychology) for her
         participation in implementing the CR in the trial, Heidi Dorthe Jensen (research nurse),
         Hanne Junge Larsen (secretary), and Merete Carlsen (laboratory technician) for their
         help with the practicalities of the trial, and Tina Dam Kristensen (MSc Psychology)
         for her help with the data collection and input for the trial.
      </p>
   </div>
</section>
<section><a name="refs"></a><h3>References</h3>
   <div id="article-references" class="collapsible-content">
      <ol id="references">
         <li id="B1">
            <p><a name="B1"></a> McGrath J,  Saha S,  Chant D,  Welham J: <strong> Schizophrenia: a concise overview of incidence, prevalence, and mortality. </strong><p><em>Epidemiol Rev</em> 2008,  <strong>30</strong><strong>:</strong>67-76.  <a target="_blank" href="/pubmed/18480098">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18480098">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B1" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B1','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B2">
            <p><a name="B2"></a> Fusar-Poli P,  Borgwardt S,  Bechdolf A,  Addington J,  Riecher-Rossler A,  Schultze-Lutter F, <em>et al</em>.: <strong> The psychosis high-risk state: a comprehensive state-of-the-art review. </strong><p><em>JAMA Psychiatry</em> 2013,  <strong>70</strong><strong>:</strong>107-20.  <a target="_blank" href="/pubmed/23165428">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=23165428">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B2" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B2','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B3">
            <p><a name="B3"></a> van der Gaag M,  Smit F,  Bechdolf A,  French P,  Linszen DH,  Yung AR, <em>et al</em>.: <strong> Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention
                  trials of 12 month and longer-term follow-ups. </strong><p><em>Schizophr Res</em> 2013,  <strong>149</strong><strong>:</strong>56-62.  <a target="_blank" href="/pubmed/23870806">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=23870806">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B3" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B3','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B4">
            <p><a name="B4"></a> McGorry PD,  Yung AR,  Phillips LJ,  Yuen HP,  Francey S,  Cosgrave EM, <em>et al</em>.: <strong> Randomized controlled trial of interventions designed to reduce the risk of progression
                  to first-episode psychosis in a clinical sample with subthreshold symptoms. </strong><p><em>Arch Gen Psychiatry</em> 2002,  <strong>59</strong><strong>:</strong>921-8.  <a target="_blank" href="/pubmed/12365879">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12365879">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B4" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B4','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B5">
            <p><a name="B5"></a> McGorry PD,  Nelson B,  Phillips LJ,  Yuen HP,  Francey SM,  Thampi A, <em>et al</em>.: <strong> Randomized controlled trial of interventions for young people at ultra-high risk of
                  psychosis: twelve-month outcome. </strong><p><em>J Clin Psychiatry</em> 2013,  <strong>74</strong><strong>:</strong>349-56.  <a target="_blank" href="/pubmed/23218022">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=23218022">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B5" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B5','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B6">
            <p><a name="B6"></a> McGlashan TH,  Zipursky RB,  Perkins D,  Addington J,  Miller T,  Woods SW, <em>et al</em>.: <strong> Randomized, double-blind trial of olanzapine versus placebo in patients prodromally
                  symptomatic for psychosis. </strong><p><em>Am J Psychiatry</em> 2006,  <strong>163</strong><strong>:</strong>790-9.  <a target="_blank" href="/pubmed/16648318">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16648318">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B6" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B6','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B7">
            <p><a name="B7"></a> Amminger GP,  Schafer MR,  Papageorgiou K,  Klier CM,  Cotton SM,  Harrigan SM, <em>et al</em>.: <strong> Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a
                  randomized, placebo-controlled trial. </strong><p><em>Arch Gen Psychiatry</em> 2010,  <strong>67</strong><strong>:</strong>146-54.  <a target="_blank" href="/pubmed/20124114">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20124114">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B7" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B7','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B8">
            <p><a name="B8"></a> Nordentoft M,  Thorup A,  Petersen L,  Ohlenschlaeger J,  Melau M,  Christensen TO, <em>et al</em>.: <strong> Transition rates from schizotypal disorder to psychotic disorder for first-contact
                  patients included in the OPUS trial. A randomized clinical trial of integrated treatment
                  and standard treatment. </strong><p><em>Schizophr Res</em> 2006,  <strong>83</strong><strong>:</strong>29-40.  <a target="_blank" href="/pubmed/16504481">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16504481">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B8" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B8','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B9">
            <p><a name="B9"></a> Bechdolf A,  Wagner M,  Ruhrmann S,  Harrigan S,  Putzfeld V,  Pukrop R, <em>et al</em>.: <strong> Preventing progression to first-episode psychosis in early initial prodromal states. </strong><p><em>Br J Psychiatry</em> 2012,  <strong>200</strong><strong>:</strong>22-9.  <a target="_blank" href="/pubmed/22075649">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22075649">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B9" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B9','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B10">
            <p><a name="B10"></a> Morrison AP,  French P,  Walford L,  Lewis SW,  Kilcommons A,  Green J, <em>et al</em>.: <strong> Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised
                  controlled trial. </strong><p><em>Br J Psychiatry</em> 2004,  <strong>185</strong><strong>:</strong>291-7.  <a target="_blank" href="/pubmed/15458988">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15458988">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B10" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B10','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B11">
            <p><a name="B11"></a> Morrison AP,  French P,  Stewart SL,  Birchwood M,  Fowler D,  Gumley AI, <em>et al</em>.: <strong> Early detection and intervention evaluation for people at risk of psychosis: multisite
                  randomised controlled trial. </strong><p><em>BMJ</em> 2012,  <strong>344</strong><strong>:</strong>e2233.  <a target="_blank" href="/pubmed/22491790">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22491790">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B11" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B11','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B12">
            <p><a name="B12"></a> Addington J,  Epstein I,  Liu L,  French P,  Boydell KM,  Zipursky RB: <strong> A randomized controlled trial of cognitive behavioral therapy for individuals at clinical
                  high risk of psychosis. </strong><p><em>Schizophr Res</em> 2011,  <strong>125</strong><strong>:</strong>54-61.  <a target="_blank" href="/pubmed/21074974">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21074974">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B12" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B12','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B13">
            <p><a name="B13"></a> van der Gaag M,  Nieman DH,  Rietdijk J,  Dragt S,  Ising HK,  Klaassen RM, <em>et al</em>.: <strong> Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis:
                  a randomized controlled clinical trial. </strong><p><em>Schizophr Bull</em> 2012,  <strong>38</strong><strong>:</strong>1180-8.  <a target="_blank" href="/pubmed/22941746">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22941746">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B13" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B13','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B14">
            <p><a name="B14"></a> Bellack AS,  Gold JM,  Buchanan RW: <strong> Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. </strong><p><em>Schizophr Bull</em> 1999,  <strong>25</strong><strong>:</strong>257-74.  <a target="_blank" href="/pubmed/10416730">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=10416730">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B14" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B14','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B15">
            <p><a name="B15"></a> Green MF,  Kern RS,  Braff DL,  Mintz J: <strong> Neurocognitive deficits and functional outcome in schizophrenia: are we measuring
                  the “right stuff”? </strong><p><em>Schizophr Bull</em> 2000,  <strong>26</strong><strong>:</strong>119-36.  <a target="_blank" href="/pubmed/10755673">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=10755673">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B15" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B15','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B16">
            <p><a name="B16"></a> Wykes T,  Spaulding WD: <strong> Thinking about the future cognitive remediation therapy–what works and could we do
                  better? </strong><p><em>Schizophr Bull</em> 2011,  <strong>37</strong>(Suppl 2)<strong>:</strong>S80-90.  <a target="_blank" href="/pubmed/21860051">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21860051">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B16" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B16','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B17">
            <p><a name="B17"></a> Green MF: <strong> What are the functional consequences of neurocognitive deficits in schizophrenia? </strong><p><em>Am J Psychiatry</em> 1996,  <strong>153</strong><strong>:</strong>321-30.  <a target="_blank" href="/pubmed/8610818">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=8610818">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B17" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B17','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B18">
            <p><a name="B18"></a> McGurk SR,  Twamley EW,  Sitzer DI,  McHugo GJ,  Mueser KT: <strong> A meta-analysis of cognitive remediation in schizophrenia. </strong><p><em>Am J Psychiatry</em> 2007,  <strong>164</strong><strong>:</strong>1791-802.  <a target="_blank" href="/pubmed/18056233">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18056233">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B18" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B18','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B19">
            <p><a name="B19"></a> Fett AK,  Viechtbauer W,  Dominguez MD,  Penn DL,  van Os J,  Krabbendam L: <strong> The relationship between neurocognition and social cognition with functional outcomes
                  in schizophrenia: a meta-analysis. </strong><p><em>Neurosci Biobehav Rev</em> 2011,  <strong>35</strong><strong>:</strong>573-88.  <a target="_blank" href="/pubmed/20620163">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20620163">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B19" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B19','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B20">
            <p><a name="B20"></a> Schmidt SJ,  Mueller DR,  Roder V: <strong> Social cognition as a mediator variable between neurocognition and functional outcome
                  in schizophrenia: empirical review and new results by structural equation modeling. </strong><p><em>Schizophr Bull</em> 2011,  <strong>37</strong>(Suppl 2)<strong>:</strong>S41-54.  <a target="_blank" href="/pubmed/21860046">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21860046">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B20" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B20','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B21">
            <p><a name="B21"></a> Green MF,  Penn DL,  Bentall R,  Carpenter WT,  Gaebel W,  Gur RC, <em>et al</em>.: <strong> Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and
                  research opportunities. </strong><p><em>Schizophr Bull</em> 2008,  <strong>34</strong><strong>:</strong>1211-20.  <a target="_blank" href="/pubmed/18184635">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18184635">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B21" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B21','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B22">
            <p><a name="B22"></a> Bartholomeusz CF,  Allott K: <strong> Neurocognitive and social cognitive approaches for improving functional outcome in
                  early psychosis: theoretical considerations and current state of evidence. </strong><p><em>Schizophr Res Treat</em> 2012,  <strong>2012</strong><strong>:</strong>815315.  <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B22" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B22','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B23">
            <p><a name="B23"></a> Addington J,  Saeedi H,  Addington D: <strong> Facial affect recognition: a mediator between cognitive and social functioning in
                  psychosis? </strong><p><em>Schizophr Res</em> 2006,  <strong>85</strong><strong>:</strong>142-50.  <a target="_blank" href="/pubmed/16678388">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16678388">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B23" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B23','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B24">
            <p><a name="B24"></a> Addington J,  Saeedi H,  Addington D: <strong> Influence of social perception and social knowledge on cognitive and social functioning
                  in early psychosis. </strong><p><em>Br J Psychiatry</em> 2006,  <strong>189</strong><strong>:</strong>373-8.  <a target="_blank" href="/pubmed/17012662">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=17012662">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B24" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B24','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B25">
            <p><a name="B25"></a> Horton HK,  Silverstein SM: <strong> Social cognition as a mediator of cognition and outcome among deaf and hearing people
                  with schizophrenia. </strong><p><em>Schizophr Res</em> 2008,  <strong>105</strong><strong>:</strong>125-37.  <a target="_blank" href="/pubmed/18722092">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18722092">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B25" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B25','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B26">
            <p><a name="B26"></a> Nienow TM,  Docherty NM,  Cohen AS,  Dinzeo TJ: <strong> Attentional dysfunction, social perception, and social competence: what is the nature
                  of the relationship? </strong><p><em>J Abnorm Psychol</em> 2006,  <strong>115</strong><strong>:</strong>408-17.  <a target="_blank" href="/pubmed/16866582">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16866582">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B26" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B26','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B27">
            <p><a name="B27"></a> Vaskinn A,  Sundet K,  Friis S,  Simonsen C,  Birkenaes AB,  Jonsdottir H, <em>et al</em>.: <strong> Emotion perception and learning potential: mediators between neurocognition and social
                  problem-solving in schizophrenia? </strong><p><em>J Int Neuropsychol Soc</em> 2008,  <strong>14</strong><strong>:</strong>279-88.  <a target="_blank" href="/pubmed/18282325">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18282325">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B27" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B27','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B28">
            <p><a name="B28"></a> Couture SM,  Penn DL,  Roberts DL: <strong> The functional significance of social cognition in schizophrenia: a review. </strong><p><em>Schizophr Bull</em> 2006,  <strong>32</strong>(Suppl 1)<strong>:</strong>S44-63.  <a target="_blank" href="/pubmed/16916889">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16916889">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B28" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B28','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B29">
            <p><a name="B29"></a> Wykes T,  Huddy V,  Cellard C,  McGurk SR,  Czobor P: <strong> A meta-analysis of cognitive remediation for schizophrenia: methodology and effect
                  sizes. </strong><p><em>Am J Psychiatry</em> 2011,  <strong>168</strong><strong>:</strong>472-85.  <a target="_blank" href="/pubmed/21406461">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21406461">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B29" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B29','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B30">
            <p><a name="B30"></a> Lewandowski KE,  Eack SM,  Hogarty SS,  Greenwald DP,  Keshavan MS: <strong> Is cognitive enhancement therapy equally effective for patients with schizophrenia
                  and schizoaffective disorder? </strong><p><em>Schizophr Res</em> 2011,  <strong>125</strong><strong>:</strong>291-4.  <a target="_blank" href="/pubmed/21167689">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21167689">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B30" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B30','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B31">
            <p><a name="B31"></a> Deckersbach T,  Nierenberg AA,  Kessler R,  Lund HG,  Ametrano RM,  Sachs G, <em>et al</em>.: <strong> RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed
                  patients with residual depressive symptoms. </strong><p><em>CNS Neurosci Ther</em> 2010,  <strong>16</strong><strong>:</strong>298-307.  <a target="_blank" href="/pubmed/19895584">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=19895584">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B31" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B31','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B32">
            <p><a name="B32"></a> Lewandowski KE,  Cohen BM,  Ongur D: <strong> Evolution of neuropsychological dysfunction during the course of schizophrenia and
                  bipolar disorder. </strong><p><em>Psychol Med</em> 2011,  <strong>41</strong><strong>:</strong>225-41.  <a target="_blank" href="/pubmed/20836900">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20836900">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B32" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B32','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B33">
            <p><a name="B33"></a> Bozikas VP,  Andreou C: <strong> Longitudinal studies of cognition in first episode psychosis: a systematic review
                  of the literature. </strong><p><em>Aust N Z J Psychiatry</em> 2011,  <strong>45</strong><strong>:</strong>93-108.  <a target="_blank" href="/pubmed/21320033">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21320033">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B33" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B33','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B34">
            <p><a name="B34"></a> Bora E,  Murray RM: <strong> Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode
                  psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? </strong><p><em>Schizophr Bull</em> 2014,  <strong>40</strong>(4)<strong>:</strong>744-55.  <a target="_blank" href="/pubmed/23770934">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=23770934">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B34" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B34','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B35">
            <p><a name="B35"></a> Fusar-Poli P,  Deste G,  Smieskova R,  Barlati S,  Yung AR,  Howes O, <em>et al</em>.: <strong> Cognitive functioning in prodromal psychosis: a meta-analysis. </strong><p><em>Arch Gen Psychiatry</em> 2012,  <strong>69</strong><strong>:</strong>562-71.  <a target="_blank" href="/pubmed/22664547">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22664547">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B35" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B35','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B36">
            <p><a name="B36"></a> Hawkins KA,  Addington J,  Keefe RS,  Christensen B,  Perkins DO,  Zipurksy R, <em>et al</em>.: <strong> Neuropsychological status of subjects at high risk for a first episode of psychosis. </strong><p><em>Schizophr Res</em> 2004,  <strong>67</strong><strong>:</strong>115-22.  <a target="_blank" href="/pubmed/14984870">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=14984870">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B36" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B36','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B37">
            <p><a name="B37"></a> Niendam TA,  Bearden CE,  Johnson JK,  McKinley M,  Loewy R,  O’Brien M, <em>et al</em>.: <strong> Neurocognitive performance and functional disability in the psychosis prodrome. </strong><p><em>Schizophr Res</em> 2006,  <strong>84</strong><strong>:</strong>100-11.  <a target="_blank" href="/pubmed/16563699">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16563699">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B37" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B37','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B38">
            <p><a name="B38"></a> Brewer WJ,  Wood SJ,  Phillips LJ,  Francey SM,  Pantelis C,  Yung AR, <em>et al</em>.: <strong> Generalized and specific cognitive performance in clinical high-risk cohorts: a review
                  highlighting potential vulnerability markers for psychosis. </strong><p><em>Schizophr Bull</em> 2006,  <strong>32</strong><strong>:</strong>538-55.  <a target="_blank" href="/pubmed/16782759">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16782759">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B38" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B38','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B39">
            <p><a name="B39"></a> Thompson AD,  Bartholomeusz C,  Yung AR: <strong> Social cognition deficits and the ‘ultra high risk’ for psychosis population: a review
                  of literature. </strong><p><em>Early Interv Psychiatry</em> 2011,  <strong>5</strong><strong>:</strong>192-202.  <a target="_blank" href="/pubmed/21726422">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21726422">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B39" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B39','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B40">
            <p><a name="B40"></a> Lin A,  Wood SJ,  Nelson B,  Brewer WJ,  Spiliotacopoulos D,  Bruxner A, <em>et al</em>.: <strong> Neurocognitive predictors of functional outcome two to 13 years after identification
                  as ultra-high risk for psychosis. </strong><p><em>Schizophr Res</em> 2011,  <strong>132</strong><strong>:</strong>1-7.  <a target="_blank" href="/pubmed/21763109">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21763109">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B40" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B40','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B41">
            <p><a name="B41"></a> Rauchensteiner S,  Kawohl W,  Ozgurdal S,  Littmann E,  Gudlowski Y,  Witthaus H, <em>et al</em>.: <strong> Test-performance after cognitive training in persons at risk mental state of schizophrenia
                  and patients with schizophrenia. </strong><p><em>Psychiatry Res</em> 2011,  <strong>185</strong><strong>:</strong>334-9.  <a target="_blank" href="/pubmed/20493540">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20493540">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B41" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B41','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B42">
            <p><a name="B42"></a> Jakobsen J,  Gluud C: <strong> The necessity of randomized clinical trials. </strong><p><em>Br J Med Clin Res</em> 2013,  <strong>3</strong>(3)<strong>:</strong>1453-68.  <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B42" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B42','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B43">
            <p><a name="B43"></a> Harvey PD: <strong> What is the evidence for changes in cognition and functioning over the lifespan in
                  patients with schizophrenia? </strong><p><em>J Clin Psychiatry</em> 2014,  <strong>75</strong>(Suppl 2)<strong>:</strong>34-8.  <a target="_blank" href="/pubmed/24919170">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=24919170">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B43" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B43','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B44">
            <p><a name="B44"></a> McGlashan TH,  Johannessen JO: <strong> Early detection and intervention with schizophrenia: rationale. </strong><p><em>Schizophr Bull</em> 1996,  <strong>22</strong><strong>:</strong>201-22.  <a target="_blank" href="/pubmed/8782282">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=8782282">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B44" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B44','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B45">
            <p><a name="B45"></a> Yung AR,  Yuen HP,  McGorry PD,  Phillips LJ,  Kelly D,  Dell’Olio M, <em>et al</em>.: <strong> Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. </strong><p><em>Aust N Z J Psychiatry</em> 2005,  <strong>39</strong><strong>:</strong>964-71.  <a target="_blank" href="/pubmed/16343296">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16343296">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B45" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B45','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B46">
            <p><a name="B46"></a> Medalia A,  Revheim N,  Herlands T: <em>Cognitive remediation for psychological disorders: therapist guide</em>.  Oxford University Press, New York: Oxford;  2009. <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B46" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B46','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B47">
            <p><a name="B47"></a> Medalia A,  Freilich B: <strong> The neuropsychological education approach to cognitive remediation (NEAR) model: practice
                  principles and outcome studies. </strong><p><em>Am J Psychiatr Rehabil</em> 2008,  <strong>11</strong><strong>:</strong>2.   <a target="_blank" href="http://dx.doi.org/10.1080/15487760801963660">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B47" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B47','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B48">
            <p><a name="B48"></a>Roberts DL, Penn DL, Combs DR. Social Cognition and Interaction Training SCIT: Treatment
               Manual. New York: Oxford University Press; In press
            </p>
         </li>
         <li id="B49">
            <p><a name="B49"></a> Ventura J,  Liberman RP,  Green MF,  Shaner A,  Mintz J: <strong> Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). </strong><p><em>Psychiatry Res</em> 1998,  <strong>79</strong><strong>:</strong>163-73.  <a target="_blank" href="/pubmed/9705054">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=9705054">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B49" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B49','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B50">
            <p><a name="B50"></a> First MB,  Gibbon M,  Spitzer RL,  Williams JBW,  Benjamin LS: <em>Structured clinical interview for DSM-IV axis II personality disorders: SCID-II</em>.  American Psychiatric Press, Washington, DC;  1997. <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B50" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B50','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B51">
            <p><a name="B51"></a> Strauss E,  Sherman EMS,  Spreen O,  Spreen O: <em>A Compendium Of Neuropsychological Tests: Administration, Norms, And Commentary</em>.  3rd edition.  Oxford University Press, New York;  2006. <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B51" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B51','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B52">
            <p><a name="B52"></a> Keefe RS,  Goldberg TE,  Harvey PD,  Gold JM,  Poe MP,  Coughenour L: <strong> The brief assessment of cognition in schizophrenia: reliability, sensitivity, and
                  comparison with a standard neurocognitive battery. </strong><p><em>Schizophr Res</em> 2004,  <strong>68</strong><strong>:</strong>283-97.  <a target="_blank" href="/pubmed/15099610">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15099610">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B52" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B52','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B53">
            <p><a name="B53"></a> Gioia GA,  Kenworthy L,  Isquith PK: <strong> Executive function in the real world: BRIEF lessons from Mark Ylvisaker. </strong><p><em>J Head Trauma Rehabil</em> 2010,  <strong>25</strong><strong>:</strong>433-9.  <a target="_blank" href="/pubmed/21076244">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21076244">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B53" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B53','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B54">
            <p><a name="B54"></a> Keefe RS,  Poe M,  Walker TM,  Kang JW,  Harvey PD: <strong> The schizophrenia cognition rating scale: an interview-based assessment and its relationship
                  to cognition, real-world functioning, and functional capacity. </strong><p><em>Am J Psychiatry</em> 2006,  <strong>163</strong><strong>:</strong>426-32.  <a target="_blank" href="/pubmed/16513863">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16513863">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B54" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B54','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B55">
            <p><a name="B55"></a> Keefe RS,  Harvey PD,  Goldberg TE,  Gold JM,  Walker TM,  Kennel C, <em>et al</em>.: <strong> Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). </strong><p><em>Schizophr Res</em> 2008,  <strong>102</strong><strong>:</strong>108-15.  <a target="_blank" href="/pubmed/18495435">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18495435">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B55" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B55','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B56">
            <p><a name="B56"></a> Levaux MN,  Potvin S,  Sepehry AA,  Sablier J,  Mendrek A,  Stip E: <strong> Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. </strong><p><em>Eur Psychiatry</em> 2007,  <strong>22</strong><strong>:</strong>104-15.  <a target="_blank" href="/pubmed/17227707">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=17227707">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B56" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B56','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B57">
            <p><a name="B57"></a> Lowe C,  Rabbitt P: <strong> Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: theoretical
                  and practical issues. Cambridge Neuropsychological Test Automated Battery. International
                  Study of Post-Operative Cognitive Dysfunction. </strong><p><em>Neuropsychologia</em> 1998,  <strong>36</strong><strong>:</strong>915-23.  <a target="_blank" href="/pubmed/9740364">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=9740364">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B57" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B57','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B58">
            <p><a name="B58"></a> Barnett JH,  Robbins TW,  Leeson VC,  Sahakiana BJ,  Joyce EM,  Blackwell AD: <strong> Assessing cognitive function in clinical trials of schizophrenia. </strong><p><em>Neurosci Biobehav Rev</em> 2010,  <strong>34</strong><strong>:</strong>1161-77.  <a target="_blank" href="/pubmed/20105440">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20105440">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B58" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B58','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B59">
            <p><a name="B59"></a> McDonald S,  Flanagan S,  Rollins J,  Kinch J: <strong> TASIT: a new clinical tool for assessing social perception after traumatic brain injury. </strong><p><em>J Head Trauma Rehabil</em> 2003,  <strong>18</strong><strong>:</strong>219-38.  <a target="_blank" href="/pubmed/12802165">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12802165">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B59" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B59','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B60">
            <p><a name="B60"></a> Gibson CM,  Penn DL,  Prinstein MJ,  Perkins DO,  Belger A: <strong> Social skill and social cognition in adolescents at genetic risk for psychosis. </strong><p><em>Schizophr Res</em> 2010,  <strong>122</strong><strong>:</strong>179-84.  <a target="_blank" href="/pubmed/20570111">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20570111">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B60" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B60','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B61">
            <p><a name="B61"></a> Kanie A,  Hagiya K,  Ashida S,  Pu S,  Kaneko K,  Mogami T,  Oshima S,  Motoya M,  Niwa SI,  Inagaki A, <em>et al</em>.: <strong> A new instrument for measuring multiple domains of social cognition: Construct validity
                  of the Social Cognition Screening Questionnaire (Japanese version). </strong><p><em>Psychiatry Clin Neurosci</em> 2014,  <strong>68</strong>(9)<strong>:</strong>701-11.  <a target="_blank" href="/pubmed/24612235">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=24612235">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B61" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B61','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B62">
            <p><a name="B62"></a> Bolte S,  Poustka F,  Constantino JN: <strong> Assessing autistic traits: cross-cultural validation of the social responsiveness
                  scale (SRS). </strong><p><em>Autism Res</em> 2008,  <strong>1</strong><strong>:</strong>354-63.  <a target="_blank" href="/pubmed/19360690">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=19360690">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B62" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B62','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B63">
            <p><a name="B63"></a> Ventura J,  Nuechterlein KH,  Subotnik KL,  Gutkind D,  Gilbert EA: <strong> Symptom dimensions in recent-onset schizophrenia and mania: a principal components
                  analysis of the 24-item Brief Psychiatric Rating Scale. </strong><p><em>Psychiatry Res</em> 2000,  <strong>97</strong><strong>:</strong>129-35.  <a target="_blank" href="/pubmed/11166085">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=11166085">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B63" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B63','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B64">
            <p><a name="B64"></a> Andreasen NC: <em>Scale for the assessment of negative symptoms: SANS</em>.  Dept. of Psychiatry, College of Medicine, the University of Iowa, Iowa City, Iowa;  1984. <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B64" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B64','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B65">
            <p><a name="B65"></a> Andreasen NC,  Flaum M,  Swayze VW 2nd,  Tyrrell G,  Arndt S: <strong> Positive and negative symptoms in schizophrenia. A critical reappraisal. </strong><p><em>Arch Gen Psychiatry</em> 1990,  <strong>47</strong><strong>:</strong>615-21.  <a target="_blank" href="/pubmed/2360855">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=2360855">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B65" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B65','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B66">
            <p><a name="B66"></a> Montgomery SA,  Asberg M: <strong> A new depression scale designed to be sensitive to change. </strong><p><em>Br J Psychiatry</em> 1979,  <strong>134</strong><strong>:</strong>382-9.  <a target="_blank" href="/pubmed/444788">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=444788">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B66" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B66','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B67">
            <p><a name="B67"></a> Young RC,  Biggs JT,  Ziegler VE,  Meyer DA: <strong> A rating scale for mania: reliability, validity and sensitivity. </strong><p><em>Br J Psychiatry</em> 1978,  <strong>133</strong><strong>:</strong>429-35.  <a target="_blank" href="/pubmed/728692">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=728692">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B67" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B67','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B68">
            <p><a name="B68"></a> Guy W: <strong> ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publ No ADM 76-338). </strong><p><em>Rockville, MD, US Department of Health, Education, and Welfare, Public Health Service,
                  Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research
                  Branch, Division of Extramural Research Programs</em> 1976, 218-22.  <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B68" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B68','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B69">
            <p><a name="B69"></a> Schultze-Lutter F,  Ruhrmann S,  Fusar-Poli P,  Bechdolf A,  Schimmelmann BG,  Klosterkotter J: <strong> Basic symptoms and the prediction of first-episode psychosis. </strong><p><em>Curr Pharm Des</em> 2012,  <strong>18</strong><strong>:</strong>351-7.  <a target="_blank" href="/pubmed/22239566">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22239566">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B69" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B69','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B70">
            <p><a name="B70"></a> Morosini PL,  Magliano L,  Brambilla L,  Ugolini S,  Pioli R: <strong> Development, reliability and acceptability of a new version of the DSM-IV Social and
                  Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. </strong><p><em>Acta Psychiatr Scand</em> 2000,  <strong>101</strong><strong>:</strong>323-9.  <a target="_blank" href="/pubmed/10782554">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=10782554">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B70" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B70','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B71">
            <p><a name="B71"></a> Hilsenroth MJ,  Ackerman SJ,  Blagys MD,  Baumann BD,  Baity MR,  Smith SR: <strong> Reliability and Validity of DSM-IV Axis V. </strong><p><em>Am J Psychiatr</em> 2000,  <strong>157</strong><strong>:</strong>1858-63.  <a target="_blank" href="/pubmed/11058486">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=11058486">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B71" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B71','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B72">
            <p><a name="B72"></a> Cornblatt BA,  Auther AM,  Niendam T,  Smith CW,  Zinberg J,  Bearden CE, <em>et al</em>.: <strong> Preliminary findings for two new measures of social and role functioning in the prodromal
                  phase of schizophrenia. </strong><p><em>Schizophr Bull</em> 2007,  <strong>33</strong><strong>:</strong>688-702.  <a target="_blank" href="/pubmed/17440198">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=17440198">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B72" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B72','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B73">
            <p><a name="B73"></a> Cannon-Spoor HE,  Potkin SG,  Wyatt RJ: <strong> Measurement of premorbid adjustment in chronic schizophrenia. </strong><p><em>Schizophr Bull</em> 1982,  <strong>8</strong><strong>:</strong>470-84.  <a target="_blank" href="/pubmed/7134891">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=7134891">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B73" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B73','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B74">
            <p><a name="B74"></a>World Health Organisation ASSIST Working Group: 
               	<strong> The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development,
                  reliability and feasibility </strong><p><em>Addiction</em> 2002,  <strong>97</strong><strong>:</strong>1183-1194.   <a target="_blank" href="http://dx.doi.org/10.1046/j.1360-0443.2002.00185.x">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B74" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B74','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B75">
            <p><a name="B75"></a> Heinrichs DW,  Hanlon TE,  Carpenter WTJR: <strong> The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. </strong><p><em>Schizophr Bull</em> 1984,  <strong>10</strong><strong>:</strong>388-98.  <a target="_blank" href="/pubmed/6474101">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=6474101">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B75" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B75','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B76">
            <p><a name="B76"></a> Larsen DL,  Attkisson CC,  Hargreaves WA,  Nguyen TD: <strong> Assessment of client/patient satisfaction: development of a general scale. </strong><p><em>Eval Program Plann</em> 1979,  <strong>2</strong><strong>:</strong>197-207.  <a target="_blank" href="/pubmed/10245370">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=10245370">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B76" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B76','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B77">
            <p><a name="B77"></a> Klingberg S,  Herrlich J,  Wiedemann G,  Wolwer W,  Meisner C,  Engel C, <em>et al</em>.: <strong> Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia:
                  results of the treatment of negative symptoms study. </strong><p><em>J Nerv Ment Dis</em> 2012,  <strong>200</strong><strong>:</strong>569-76.  <a target="_blank" href="/pubmed/22759932">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22759932">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B77" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B77','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B78">
            <p><a name="B78"></a> Brewer WJ,  Francey SM,  Wood SJ,  Jackson HJ,  Pantelis C,  Phillips LJ, <em>et al</em>.: <strong> Memory impairments identified in people at ultra-high risk for psychosis who later
                  develop first-episode psychosis. </strong><p><em>Am J Psychiatry</em> 2005,  <strong>162</strong><strong>:</strong>71-8.  <a target="_blank" href="/pubmed/15625204">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15625204">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B78" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B78','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B79">
            <p><a name="B79"></a> Becker HE,  Nieman DH,  Wiltink S,  Dingemans PM,  van de Fliert JR,  Velthorst E, <em>et al</em>.: <strong> Neurocognitive functioning before and after the first psychotic episode: does psychosis
                  result in cognitive deterioration? </strong><p><em>Psychol Med</em> 2010,  <strong>40</strong><strong>:</strong>1599-606.  <a target="_blank" href="/pubmed/20132582">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20132582">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B79" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B79','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B80">
            <p><a name="B80"></a> Frommann I,  Pukrop R,  Brinkmeyer J,  Bechdolf A,  Ruhrmann S,  Berning J, <em>et al</em>.: <strong> Neuropsychological profiles in different at-risk states of psychosis: executive control
                  impairment in the early–and additional memory dysfunction in the late–prodromal state. </strong><p><em>Schizophr Bull</em> 2011,  <strong>37</strong><strong>:</strong>861-73.  <a target="_blank" href="/pubmed/20053865">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20053865">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B80" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B80','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B81">
            <p><a name="B81"></a> Eastvold AD,  Heaton RK,  Cadenhead KS: <strong> Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. </strong><p><em>Schizophr Res</em> 2007,  <strong>93</strong><strong>:</strong>266-77.  <a target="_blank" href="/pubmed/17467955">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=17467955">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B81" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B81','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B82">
            <p><a name="B82"></a> Nasrallah H,  Morosini P,  Gagnon DD: <strong> Reliability, validity and ability to detect change of the Personal and Social Performance
                  scale in patients with stable schizophrenia. </strong><p><em>Psychiatry Res</em> 2008,  <strong>161</strong><strong>:</strong>213-24.  <a target="_blank" href="/pubmed/18848731">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18848731">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B82" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B82','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B83">
            <p><a name="B83"></a> Ballerini A,  Boccalon R,  Boncompagni G,  Casacchia M,  Margari F,  Minervini L, <em>et al</em>.: <strong> An observational study in psychiatric acute patients admitted to General Hospital
                  Psychiatric Wards in Italy. </strong><p><em>Ann Gen Psychiatry</em> 2007,  <strong>6</strong><strong>:</strong>2.  <a target="_blank" href="/pubmed/17257438">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://dx.doi.org/10.1186/1744-859X-6-2">BioMed&nbsp;Central&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B83" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B83','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B84">
            <p><a name="B84"></a> Lepping P,  Sambhi RS,  Whittington R,  Lane S,  Poole R: <strong> Clinical relevance of findings in trials of antipsychotics: systematic review. </strong><p><em>Br J Psychiatry</em> 2011,  <strong>198</strong><strong>:</strong>341-5.  <a target="_blank" href="/pubmed/21525517">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21525517">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B84" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B84','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B85">
            <p><a name="B85"></a> Savovic J,  Jones HE,  Altman DG,  Harris RJ,  Juni P,  Pildal J, <em>et al</em>.: <strong> Influence of reported study design characteristics on intervention effect estimates
                  from randomized, controlled trials. </strong><p><em>Ann Intern Med</em> 2012,  <strong>157</strong><strong>:</strong>429-38.  <a target="_blank" href="/pubmed/22945832">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22945832">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B85" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B85','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B86">
            <p><a name="B86"></a> Eack SM,  Greenwald DP,  Hogarty SS,  Cooley SJ,  DiBarry AL,  Montrose DM, <em>et al</em>.: <strong> Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year
                  randomized controlled trial. </strong><p><em>Psychiatr Serv</em> 2009,  <strong>60</strong><strong>:</strong>1468-76.  <a target="_blank" href="/pubmed/19880464">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=19880464">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0542-8&amp;bibl=B86" onclick="popup('/sfx_links?ui=s13063-014-0542-8&amp;bibl=B86','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
      </ol>
   </div>
</section>
    <br class="clearall">
<div class="article-alert-signup-div">

<a class="close png_bg" id="closeHelpBox" >close</a>	
<div class="article-alert-signup rounded" > 
<span class="blurb left">Sign up to receive new article alerts from <em>Trials</em></span>

	
				<button name="articleAlertPreference.status" type="button" class="w74 right" onClick="window.location='/my/preferences'">Sign up</button>
	
</div>
</div></div>
    </div></div>
</div>


		</div>
</div>

    <hr class="hide" />
	
    

						
   
  
      
  
                  
  
                  
  
            
  
            
            


<div id="footer">

						
			<span class="views"><a id="mobile-view" href="?fmt_view=mobile">Mobile view</a> | <strong>Desktop view</strong></span>
			
	<div class="content">
    <div class="rounded ">
<div class="wrap-inner ">
        	
    <ul class="desktop">
                                                    
				        <li class="noborder"><a href="http://www.biomedcentral.com/about/tandc">Terms and Conditions</a></li>
<li><a href="http://www.biomedcentral.com/about/privacy">Privacy statement</a></li>
<li><a href="http://www.biomedcentral.com/presscenter">Press</a></li>
	<li><a href="http://www.biomedcentral.com/advertisers">Information for advertisers</a></li>
<li><a href="http://www.biomedcentral.com/about/bmcjobs">Jobs at BMC</a></li>
<li><a href="/support">Support</a></li>
<li><a href="/about/contact">Contact us</a></li>


    
    	    </ul>
    <p id="copyright">&copy; 2015 
	BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business&nbsp;Media.</p>
        </div>
</div>

	</div>

</div>
<div class="springer">
    <a href="http://www.springer.com/" target="blank"><img style="float:right; margin:0;" src="
    //www.biomedcentral.com/images/Springer_Branding_footer_logo.png" /></a>
</div>


<script>window.bmcIsMobile = "classic";</script>					    

<script>
// getElementsByClassName Polyfill
var getElementsByClassName=function(e,t,n){if(document.getElementsByClassName){getElementsByClassName=function(e,t,n){n=n||document;var r=n.getElementsByClassName(e),i=t?new RegExp("\\b"+t+"\\b","i"):null,s=[],o;for(var u=0,a=r.length;u<a;u+=1){o=r[u];if(!i||i.test(o.nodeName)){s.push(o)}}return s}}else if(document.evaluate){getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i="",s="http://www.w3.org/1999/xhtml",o=document.documentElement.namespaceURI===s?s:null,u=[],a,f;for(var l=0,c=r.length;l<c;l+=1){i+="[contains(concat(' ', @class, ' '), ' "+r[l]+" ')]"}try{a=document.evaluate(".//"+t+i,n,o,0,null)}catch(h){a=document.evaluate(".//"+t+i,n,null,0,null)}while(f=a.iterateNext()){u.push(f)}return u}}else{getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i=[],s=t==="*"&&n.all?n.all:n.getElementsByTagName(t),o,u=[],a;for(var f=0,l=r.length;f<l;f+=1){i.push(new RegExp("(^|\\s)"+r[f]+"(\\s|$)"))}for(var c=0,h=s.length;c<h;c+=1){o=s[c];a=false;for(var p=0,d=i.length;p<d;p+=1){a=i[p].test(o.className);if(!a){break}}if(a){u.push(o)}}return u}}return getElementsByClassName(e,t,n)}
</script>

						



<script type="text/javascript">
if (typeof jQuery == 'undefined') { document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.min.js' type='text/javascript'%3E%3C/script%3E")); }


document.documentElement.id = "js";

var site = {
			abbreviation: "",
	        type: "BMC_NICHE",
        portalId: "9001",
                section: "browse",
                page: "fulltext",
    		
									homePortal: "biomedcentral.com",
		
			siteShowAds: "true",
				showAds: "true",
				url: "trialsjournal.com",
			portal: false,
	        adpage_url: "trialsjournal.com/article/10.1186/s13063/014/0542/8",
        id: "10096",
	name: "Trials",
	plugins: {
		scrollable: (getElementsByClassName("scrollable").length > 0),
				flowplayer: ((document.getElementById("flowplayer") != null) || (getElementsByClassName("myPlayer").length > 0) || (document.getElementById("videoarticle") != null) || (getElementsByClassName("flowplayer").length > 0) || (document.getElementById("audio") != null) || (document.getElementById("elifeplayer") != null)),
		lightbox: ((document.getElementById("image-highlight") != null) || (getElementsByClassName("lightbox").length > 0)),
		thickbox: (getElementsByClassName("thickbox").length > 0),
		altmetric: ((document.getElementById("altmetric") != null) || (getElementsByClassName("altmetric").length > 0))
	}
	
};



if(typeof quoteSearchUri == "undefined") { quoteSearchUri=null; }
</script>



        <script type="text/javascript" src="http://www.bmcimg.com/javascript/journals/behaviours-0.js"></script>






		<script>
	if (site.plugins.scrollable == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.scrollable-1.0.1.min.js' %3E%3C/script%3E")); 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.tools.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.flowplayer == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/flowplayer-3.2.6.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.lightbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/browse_imagehighlight.js'%3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.colorbox.js' %3E%3C/script%3E"));
	}

	if (site.plugins.thickbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-compressed.js' %3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-flashhidden-patch.js' %3E%3C/script%3E"));
	}
	</script>





            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.fancybox-1.3.1.pack-0.js"></script>
            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.debug-0.js"></script>
                      <script type="text/javascript" src="http://www.bmcimg.com/javascript/email_preferences/email_preferences-0.js"></script>
                <script type="text/javascript" src="http://www.bmcimg.com/javascript/articles/articles-0.js"></script>
		<div id="fb-root"></div>











        <script type="text/javascript" src="/javascript/plugins/jquery.tagcloud.min-0.js"></script>




<!--[if lte IE 6]>
            <script type="text/javascript" src="/javascript/plugins/DD_belatedPNG_0.0.8a-0.js"></script>
    <script type="text/javascript">
        DD_belatedPNG.fix('.png_bg, ul.primary-nav li a, ul.primary-nav li a span, ul.secondary-nav li a, ul.secondary-nav li a span, ul li i, .plus-button, .facebook, .twitter, .fancy-bg, #fancybox-close');
    </script>
	                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/hacks/ie6-0.css"/>
    <![endif]-->

<!-- Claudia Whitcombe wanted this comment here -->

       <div class="hide">
      <dl class="google-ad" id="x96banner">
        <dt style="display: block;" class="hide">
          <a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
       </dt>
        <dd>
          <!-- OAS AD 'x96' begin -->
          <script type="text/javascript">
            OAS_AD('x96');
          </script>
        </dd>
      </dl>
    </div>  
    
</body>
</html>

